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ABSTRACT 
 
 
 Articular cartilage is a highly specialized tissue which when damaged, represents poor 
potential of self-regeneration. Very often standard medical interventions are not sufficient to 
treat cartilage defects hence, tissue engineering techniques have started to play a key role in 
cartilage restoration. Collagen type I and its denatured form, gelatin are in the centre of the most 
common biomaterials used in tissue engineering due to their biodegradability, low cytotoxicity 
and promotion of cell adhesion. However, without suitable stabilization, these natural polymers 
can degrade quickly in the physiological conditions as well as under mechanical load. In order 
to enhance chemical stability, structural integrity and stiffness of the biomaterials different 
crosslinking methods (reinforcement) were applied to produce 3D porous polymer scaffolds, 
which were deeply investigated physicochemically, mechanically and biologically.  
 The first study of this PhD thesis tends to investigate the feasibility of developing 3D gelatin 
scaffolds through stabilization by physical (DHT), chemical (BDDGE) and natural (Genipin) 
crosslinking approaches. The study aimed at comparatively assessing the porous microstructure 
and the long-term resistance of the scaffolds upon degradation in wet physiological conditions 
(37 °C, pH = 7.4). The degree of crosslinking increases as function of incorporation of 
crosslinkers, which was maximum up to 73% for BDDGE. The infrared spectroscopy and 
thermal analysis confirmed the gelatin structure was preserved during the crosslinking 
treatments. Mechanical properties of the scaffolds were analysed by static and dynamic 
compression test, which showed different viscoelastic behaviour upon various reinforcement 
strategies with the highest compressive modulus for DHT-crosslinked scaffold. 
Cytocompatibility, bioactivity and overall cell-scaffold interaction was investigated using 
human osteoblast-like cells and human chondrocytes showing good cell adhesion, viability and 
proliferation, as well as extensive 3D scaffold colonization. Additionally, the analysis of gene 
and protein expression as well as glycosaminoglycans content related to the formation of neo 
cartilage tissue, reported increasing ability with time in the formation of new extra-cellular 
matrix. In conclusion, out of three different crosslinking methods, the gelatin scaffolds 
subjected to dehydrothermal treatment (DHT) represented to be the most favourable 3D 
scaffold for cartilage regeneration. 
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 In the second study, ribose was proposed as a promising, non-toxic, low-cost crosslinker to 
improve stability and rigidity of type I collagen matrices. The main objective was to determine 
optimal conditions of glycation by ribose to fabricate 3D porous collagen scaffolds and to verify 
their effectiveness for use as scaffolds for cartilage tissue engineering, by physicochemical and 
biological characterization. Two different crosslinking strategies were investigated including 
variety in the amount of ribose and the time of reaction: pre-crosslinking (PRE) and post-
crosslinking (POST). All ribose-glycated collagen scaffolds demonstrated good swelling 
properties and interconnected porous microstructure suitable for cell growth and colonization. 
POST samples showed to be superior than PRE in terms of porosity, crosslinking degree, fluid 
uptake ability and resistance to enzymatic digestion. Moreover, mechanical properties of the 
scaffolds were significantly improved upon glycation when compared to non-crosslinked 
collagen, manifesting the best performance for POST matrices crosslinked for 5 days and in the 
highest amount of sugar. In vitro studies analysing cell-material interactions revealed scaffolds 
cytocompatibility with higher cell viability and cell proliferation as well as higher 
glycosaminoglycans secretion for POST scaffolds respect to PRE. This report demonstrated 
feasibility of developing 3D collagen scaffolds by ribose glycation and highlighted POST-
crosslinking strategy as a more favourable than PRE-crosslinking to achieve scaffolds suitable 
for cartilage regeneration. 
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PART I 
INTRODUCTION 
 
 
 Tissue engineering (TE) is a multidisciplinary field constantly bringing more and more 
attention and which can completely change the view of future medicine [1]. Thanks to TE, 
poorly healing defects like cartilage defects can be potentially treated with combination of 3D 
scaffolds, cells and bioactive factors in order to regenerate damaged tissue. The ideal 
perspective in the scientific and medical environment is that, every tissue could be replaced or 
regenerated by tissue engineering techniques thereby, increasing survival and quality of our 
lives [2]. Articular cartilage tissue was one of first tissues thought to be profitably engineered 
however, the only one product approved by Food and Drug Administration so far, reveals a 
challenging nature of this approach [3]. Indeed, it is extremely difficult to mimic the complex 
architecture and biomechanics of native tissue. Many attempts have been made to create a 
functional cartilage engineered construct and only a few studies reached the clinical level. 
Hence, materials and fabrication technologies are highly important in designing and producing 
biomimetic three-dimensional (3D) templates (scaffolds) for new tissue formation [4].    
 The research presented in this work is focused on 3D natural polymer-based scaffolds for 
cartilage TE and on their deep investigation concerning different crosslinking strategies. 
Nevertheless, before that it is necessary to well understand articular tissue composition, 
structure and properties, which were described precisely in the following chapter. Then, in 
further chapters of part I concept of tissue engineering as well as natural polymer scaffolds and 
diverse crosslinking methods are briefly discussed.  
 
1. Cartilage tissue 
 Cartilage is a viscoelastic connective tissue that together with bone tissue serve as support 
for the skeleton [5]. Formulation of cartilage begins in the embryonic phase of human 
development and its major part is later replaced by bone formation. Importance of cartilage 
comes from the fact that this tissue provides an interface between bones minimizing in this way 
4 
 
load bearing and friction of bones. Cartilage by its action allows for bone’s rotation and 
influences all locomotor system. Therefore, cartilage tissue is indispensable for the body motion 
as well as for the protection of bones at joints [6] . Cartilage can be found in the areas of ears, 
nose, trachea, intervertebral disks, ribs, joints and in many more parts of the human body. This 
tissue occurs in three forms [7]: 
a) Fibrocartilage – the strongest cartilage; existing for instance in intervertebral disks and 
meniscus; presence of large amount of collagen I; 
b) Elastic cartilage – appearing in the ear lobe, trachea and epiglottis; abundance of elastic 
fibers makes this form of cartilage highly elastic; 
c) Hyaline cartilage – present in hip, elbow, shoulder, and knee joints where is also named 
articular cartilage; presence of large amount of collagen II [7].   
 
1.1. Composition of articular cartilage 
 Articular cartilage is a thin and connective tissue which covers the surfaces of diarthrodial 
joints [8]. The tissue is white in colour due to the lack of vascularity and forms a layer around 
3 mm thick (Fig. 1.1 A). The main components of articular cartilage are water which is the only 
component of fluid phase and extra cellular matrix (ECM), belonged to the solid phase (Fig. 
1.1 B). The fluid component includes a major part of the tissue because even 80% of the total 
volume.  
 
Fig. 1.1 (A) Design of knee joint with underlined articular cartilage, which covers the end of 
the bones. White colour of articular cartilage is correlated to lack of vascularization. (Adapted 
from www.londonkneeclinic.com) (B) Diagram presenting approximately amounts (%) of 
articular cartilage components. Solid phase contains collagen II, proteoglycans, other collagens 
and very little amount of non-collagenous proteins as glycoproteins, fibronectin etc. (no added 
on the graph). Liquid phase contains water and electrolytes [9].  
15%
10%
1%
5%
69%
collagen II
proteoglycans
other collagens
chondrocytes
water
A B 
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The rest is ECM and chondrocytes, the only cell type present in cartilage, which are account 
for approximately (1-5%). Moreover, ECM is composed of mostly type II collagen (15-20%), 
other types of collagen (2%), proteoglycans (10%) and non-collagenous proteins (Fig. 1.1 B) 
[8]. 
 Chondrocytes in an adult articular cartilage have very limited proliferative potential and 
their main role is to preserve the tissue composition by synthesis and production of ECM 
components [10]. Additionally, chondrocytes can sense and respond to the different mechanical 
stimuli thus, they contribute indirectly to the biomechanics of cartilage [11].  
 Chondrocytes are derived from mesenchymal stem cells (MSCs), which in turn originate 
from mesoderm, one of the three germ layers, developed during embryogenesis [12]. MSCs as 
multipotent cells can differentiate into various cell types creating at the end different tissues as 
cartilage, bone or muscle tissue. In order to create cartilage lineage, MSCs have to condensate 
and then undergo chondrogenesis process in which prechondrogenic cells differentiate through 
chondroblasts into chondrocytes [12], [13]. Chondrogenesis is a process demanding suitable 
conditions and several key regulators [14], [15]. Terminal differentiation occurs when mature 
chondrocytes become hypertrophic and the process of bone formation is started [16]. Articular 
cartilage is progressively mineralized and blood vessels are promoted. Maturation of articular 
cartilage in humans takes around 18-21 years and during this time remodelling of cell 
functionality, phenotype and the EMC deposition occurred. Although, in the early stages of 
tissue maturation chondrocytes proliferate in a high extent, the mature chondrocytes decreased 
completely their proliferative and metabolic activity resulting in weak healing capacity upon 
injuries [8], [11].  
 Mature chondrocytes have a spherical shape with flattened edges, abundant Golgi apparatus 
and rough endoplasmic reticulum and noticeable nucleus. The cell-cell interaction among 
chondrocytes did not exist and the matrix around the cells is termed as pericellular matrix [17]. 
Phenotype of chondrocytes depends on the architecture and composition of the growing 
environment, thus chondrocytes cultured in monolayer in vitro lose their original phenotype. 
Some variability in the shape can be a result of slight differences in gene expression, several 
signalling pathways and differences in synthesis of matrix-specific components [5], [15]. 
Moreover, single cellular behaviour can be influenced by compressive load applied to the cells, 
and this phenomenon is called mechano-transduction [18]. Some differences in the 
chondrocytes phenotype and metabolic activity can be noticed also due to different cell 
localization inside cartilage tissue [10].  
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 Cells are estimated to occupy only a little part of entire articular cartilage. As has been 
mentioned above high percentage of total tissue volume belongs to type II collagen (collagen 
II) and other forms of this protein. Collagen possesses 28 isoforms that have been discovered 
so far [19]. Collagen is the main structural component of connective tissues; it is the most 
abundant protein in mammals, making up from 25% to 35% of the whole-body protein content. 
Chondrocytes produce collagen in the form of soluble procollagen trimers that next undergo 
enzymatic processes to obtain collagen fibres. Although collagen can emerged in globular form, 
fibril form is the most numerous group in articular cartilage [20]. More about collagen structure 
is described in the further chapters.  
 Collagen II is the main type in hyaline cartilage and it contributes to mechanical tensile 
properties of tissue. Other collagen isoforms as collagen VI, IX, X and XI are present in 
cartilage tissue and their amounts change depending on the age. For instance with maturation, 
proportion of collagen XI respect to other collagens decreases from 10% of fetal cartilage to 
3% of adult cartilage. Each type of collagen family can be localized in a different depth of tissue 
and represent different function [7], [8]. Another very abundant in the human body form of 
collagen is type I collagen (collagen I) which can be found only on the surface of cartilage, as 
this protein is a main component of the organic part of bone [8]. In research the ratio between 
collagen II and collagen I is used as an indicator during differentiation experiments to 
distinguish hyaline and fibrocartilage as well as verify the state of chondrocytes differentiation 
[10].  
 One more important group of ECM components are proteoglycans, special class of 
glycoproteins that play structural, mechanical and regulation role in articular cartilage. 
Proteoglycans are consistent of a "core protein" with one or more covalently attached 
glycosaminoglycan (GAG) chain(s) [20]. GAGs are long, unbranched, polysaccharides 
consisting of a repeating disaccharide unit. To the most common GAGs belong: chondroitin 
sulfate, keratin sulfate, dermatan sulfate and hyaluronan, which is the largest one. Hyaluronan 
binds aggrecan, the main proteoglycan present in cartilage, by a "link protein" creating a strong 
bound and thereupon, proteoglycan aggregates can be formed. These aggregates possess 
negative charge that promotes specific osmotic pressure interacting with synovial fluid called 
as Donnan effect. The osmotic pressure contributes to swelling and manages water amounts 
within the tissue. Moreover, collagen fibers keep together whole matrix structure with GAG 
chains and aggrecan supporting cartilage amortization against compression. Therefore, 
degradation of proteoglycans can be a significant factor in joint disease as osteoarthritis (OA) 
[21].  
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The last important component of articular cartilage that I would like to mention is synovial 
fluid (synovia) [8]. Synovial fluid is a viscous liquid, characterized as non-Newtonian fluid 
present in the cavities of synovial joints. Synovial fluid contains hyaluronan, protein-rich 
plasma, electrolytes and superficial zone protein (SZP), also known as PRG4 or lubricin. Thank 
to this protein, synovial fluid acts as a lubricant protecting articulating joints from frictions. 
Furthermore, synovia plays role in nutrients transport and waste removal and what is more 
important, it is responsible for support the load bearing capacity of cartilage. Basically, synovial 
fluid increase its viscosity when pressure increased which results in joints protection upon 
loading [7]. 
 
1.2. Structure and mechanical characterization of articular cartilage 
Architecture of cartilage is a complex form which varies in ECM composition, density, 
collagen fibers assembling, phenotype and activity of chondrocytes. Four zones can be 
distinguish within articular cartilage tissue starting from the top layer (Fig. 1.2) [9]:  
a) Superficial zone, 
b) Middle zone (or transitional), 
c) Deep zone (or radial), 
d) Calcified zone.  
 Each zone has its own particular role that has impact on functionality the whole articular 
cartilage. In addition, cells from different zones may respond to mechanical forces in different 
ways and exhibit diverse morphologies [11].  
Starting from the top, the superficial zone encompasses only 10–20% of the total tissue 
thickness, but the amount of collagen in this area is the highest (Fig. 1.2). However, collagen 
fibers are the thinnest, densely packed and positioned parallel to the surface to form the layer 
known as lamina splendens. Chondrocytes in this zone appear also in high densities with 
parallel position to the surface and flattened morphology. Less proteoglycans compared to other 
zones leads to a high fluid permeability. Architecture of this zone is correlated to tensile strength 
and to decrease of high shear forces [16], [22].  
Middle zone, referred also as transitional zone mediates between superficial and deep zone. The 
amount of collagen decreased compared to superficial zone, the fiber diameter enlarges and 
they adopt random organization. Chondrocytes changed their morphology for the round shape. 
Additionally, characteristic feature of the middle zone is a high density of proteoglycans (Fig. 
1.2) [1].  
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Fig. 1.2. Schematic illustration of composition and organization of articular cartilage. Four 
different zones can be distinguished: Superficial zone, middle zone, deep zone and calcified 
zone. Subchondral bone aligned under the cartilage is also presented [9].  
 
In the deep zone, collagen fibers are the thickest and oriented perpendicularly to the surface. 
These collagen fibers are able to create a strong bridge between cartilage and bone. 
Chondrocytes are arranged in columns along with collagen fiber, also perpendicularly to the 
articulating surface (Fig. 1.2) [1] .   
The last one, calcified zone can be found between the deep zone and subchondral bone (Fig. 
1.2). Only single chondrocytes are presented here, and production of the collagen II is reduced, 
in contrast to high production of collagen X which supports mineralization [20]. 
Articular cartilage is characterized as an anisotropic and viscoelastic tissue thus, it shows 
non-linear response due to application of mechanical forces [6]. Mechanical behaviors as stress-
relaxation or creep are time-dependent and they are strongly related to the permeability of 
tissue. Cartilage is comparable to the sponge in which fluid can flow through, however with a 
low rate. At the beginning of deformation, flow rate starts to drop increasing the drag forces. In 
consequence cartilage increased the hydraulic pressure and mechanical stiffening [6], [11]. As 
cartilage is composed of two phases: liquid and solid, which interacting with each other to 
determine viscoelastic properties of tissue, biphasic cartilage model has been proposed [23]. In 
this model solid component containing collagen, proteoglycans cells and other small proteins 
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is described as incompressible elastic material and interstitial fluid component is modeled as 
non-viscous phase. Under compression, friction is generated between liquid and solid phase 
resulting that fluid flows out from the collagen-proteoglycan solid matrix and this drag 
compensates the load applied to cartilage tissue. When the load is removed tissue return to its 
original form, the fluid is restored into the compressed area as well as the elasticity of the solid 
component is returned [23].  
Compressive moduli of the cartilage can vary depends on depth and location. The 
compressive aggregates modulus of articular joints is ranged from 0.08 MPa in the superficial 
zone up to 2 MPa in the middle and deep zone [24]. This difference can be related to decrease 
of fluid flow in the middle and deep zones, which leads to smaller strains in these areas. 
Another mechanical properties that can be distinguished regarding cartilage tissue are 
tensile properties [10]. Tensile properties are influenced by collagen fibrils, and obviously the 
tensile moduli change among the zones of cartilage since thickness and organization of collagen 
fibers change as well. Tensile modulus (Young’s modulus) can reach between 5 and 25 MPa 
being the highest in superficial zone, which can be associated to the highest content of collagen 
in this zone [6].  
 
2. Cartilage defects and their regeneration 
2.1. Articular cartilage defects and diseases  
 Articular cartilage defects can be caused by various factors as unusual loading of the joint, 
overloading, wear and tear overtime and also traumatic events. Cartilage defects left untreated 
can lead to degenerative joint disease, osteoarthritis [9]. Independently on the cause of defect, 
cartilage injuries can be divided into two groups: partial-thickness (chondral) and full-thickness 
(osteochondral) defects [25]. In chondral defects, damages are made to the cartilage layers 
without reaching the bone whereas, in osteochondral lesions an injury reaches the subchondral 
bone. As articular cartilage is a avascular tissue blood or bone cells as well as progenitor cells 
in bone marrow cannot access to it thus, the healing response is limited [17]. Chondrocytes 
feature low proliferation and migration rate, which also make complete regeneration of the 
defect difficult to accomplish. In osteochondral injuries blood cells and mesenchymal 
progenitor cells have access to the damaged cartilage from subchondral bone and the 
regeneration process can start [9]. Even if mesenchymal stem cells have capacity to restore the 
tissue by fast proliferation and differentiation into chondrocytes rather than hyaline cartilage, 
fibrous cartilage is forming. Fibrous cartilage (fibrocartilage) has weak mechanical properties 
10 
 
and the injury can easily appeared again. As can be noticed ability of spontaneous healing the 
cartilage defects is extremely limited and often results in osteoarthritis (OA) [26].  
 OA is a serious and wide-spread disease nowadays because it leads to joint pain, movement 
impairment, inflammation and overall deteriorated quality of life. Hip and knee OA are the 11th 
leading cause of disability as announced World Health Organization (WHO) Global Burden of 
Disease Study 2010. At the moment Over 70 million Europeans suffer from knee OA [27]. 
Joints altered by osteoarthritis demonstrate, inter alia, decrease in collagen and proteoglycan 
content, increase of the water content, fibrillation, inflammation of the synovium and thickening 
of the subchondral bone. The details of biological changes in OA can be found in a growing 
number of literature studying this problematic disease [3].  
 
2.2. Medical interventions in cartilage repair 
 There are three main medical techniques used in clinical practice for treatment of cartilage 
defects [9], [10]: 
a)  Microfracture, 
b)  Autologous chondrocyte implantation (ACI), 
c)  Auto- and allografts.  
 Microfracture is chirurgical procedure which goal is to make a small holes in the 
subchondral bone in order to deliver blood with bone marrow mesenchymal stem cells 
(BMSCs) [10]. BMSCs with their high capacity of self-renewal and differentiation can rebuild 
the damage tissue. Very often, similarly as in osteochondral defects instead of hyaline cartilage 
fibrocartilage is formed which is too mechanically weak to resist load-bearing of the joint ant 
thus, effectiveness of microfracture surgery is limited. Microfracture can be appropriate for 
treatment of small defects, in relatively young patients who have faster healing response [25].  
 Autologous chondrocyte implantation (ACI) was the first method of cell transplantation for 
cartilage repair and became very common since 1990 [28]. ACI is comprised of two steps: 
arthroscopy and surgery. At first, biopsy of healthy cartilage is performed from the low weight-
bearing area of patient’s knee and chondrocytes are isolated and expanded in vitro for several 
weeks to significantly amplify number of cells. At the second step cells are injected to the lesion 
and periosteal patch or synthetic collagen is applied to cover the surface of the drilled area [9]. 
Although ACI procedure succeed in numerous of patients there some disadvantages as long 
recovery time or many surgeries required to sufficiently harvest cartilage tissue. Furthermore, 
difficulties in optimization of cell number and satisfactory differentiation as well possibility to 
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occur periosteal hypertrophy can be a limitation of this technique [29]. ACI technique was 
evaluated over years to second-generation ACI where periosteal patch were replaced by 
collagen membrane and further third-generation known as matrix-assisted ACI (MACI). In 
MACI procedure autologous chondrocytes are expanded and seeded onto the scaffold which is 
further implanted into defect [4]. 
 Autografts and allografts are other, very popular options for cartilage regeneration [30]. 
Briefly, a piece of healthy cartilage belonged to low weight-bearing area is harvested from the 
patient with a part of subchondral bone (osteochondral autograft) or is taken from cadaveric 
donor from tissue banks (osteochondral allograft). Then, the healthy piece of tissue is implanted 
into defect and regeneration process can occur [30]. Autografting technique have showed some 
satisfactory clinical results however, many limitations to this procedure are present. First of all, 
insufficient amount or quality of tissue material which is going to be implanted can create 
problems. Moreover, disadvantage can be a mismatch of the graft and the implant site as the 
first one can be a part of low weight-bearing and the second one can be a part of high weight-
bearing area. Finally, poor stability of the graft and donor site morbidity are the limitation of 
autografting. Nevertheless, decreasing amount of tissue material that has to be implanted and 
implanting many small grafts into one defect site can improve the outcome [26], [31].  
Allograft used as an alternative to autograft can fill bigger defect size and there are not high 
limitation to the amount of donor tissue available as well as the donor side morbidity is avoided. 
However, immuno-rejection and disease transmission can be an issue in case of allografting 
[30].  
 All presented above procedure are not sufficient when the defect size is too big or joint 
injuries are serve or progressive OA is developed [27]. Articular cartilage cannot be restored 
by any of interventions discussed above and partial or total joint replacements are necessary. In 
a place where joint has been removed partially or totally artificial implant consisted mainly of 
metal and small polymer piece is implanted. Although newly produced implants are improved 
every year, complications as implant loosening, infection, and short life spans of the implants 
occur very often and second surgery is necessary [30]. As we can see, medical interventions for 
cartilage regeneration currently available have many limitations and no ideal standard treatment 
is present. Thereby, searching for alternative solutions in the field of regenerative medicine and 
the concept of tissue engineering has been raised.  
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3.  Cartilage tissue engineering 
3.1. The concept of tissue engineering  
 The first trace of tissue replacement was dated on 1597 when Gasparo Tagliacozzi, 
Professor of Surgery and Anatomy at the University of Bologna described the nose 
reconstruction with a forearm flap that he performed [32]. A few centuries after, in 1985, the 
idea and the term of tissue engineering (TE) has been proposed by Y.C. Fung, a pioneer of the 
field of biomechanics and of bioengineering, entitled as: “Center for the Engineering of Living 
Tissues” [33]. The proposal of Fung was not accepted and the definition of TE has been 
evolving for several years to finally define as: “Tissue engineering is an interdisciplinary field 
that applies the principles of engineering and the life sciences toward the development of 
biological substitutes that restore, maintain, or improve tissue function.” This interpretation of 
the TE term was proposed by Robert Langer and Joseph P. Vacanti in the May 14, 1993 issue 
of Science [34]. By now 82 740 articles can be found on PubMed database using the string 
“tissue engineering”, indicating on rapidly growing progress and interests in this field.  
 In fact, TE is area which includes combination of various materials, cells and biologically 
active molecules to improve or replace biological tissues [35]. The aim of this discipline is to 
create functional constructs which are able to rebuild and recover damaged tissue or even whole 
organs. The term of regenerative medicine is often used parallel to TE however, regenerative 
medicine is focused on incorporation of stem cells to restore tissues or organs. The materials 
which are fabricated to support tissue regeneration, called also biomaterials or scaffolds due to 
3D architecture, have been in the center of attention since decades and can be considered as a 
separate sub-field of TE [30].  
Fig. 1.3 presents simplified scheme of TE approach. Following the illustration firstly piece of 
tissue is harvested from the patient and autologous cells are expanded in vitro in 2D. 
Afterwards, cells can be combine with the 3D scaffolds or other type of matrices or/and 
biological molecules (e.g. growth factors) to provide suitable conditions for new tissue 
organization. Such an engineered tissue-like construct is transplanted into place of damaged 
tissue in patient’s body and regeneration can occur (Fig. 1.3). Depends on the type of tissue that 
has to be recreated different types of materials, cells and biological factors need to be applied 
regarding specific structural and mechanical properties of the tissue [2]. 
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Fig. 1.3 Schematic illustration of the tissue engineering concept. Five different steps can be 
distinguished as follows: 1) Tissue harvesting; 2) 2D cell expansion; 3) Cell seeding on 3D 
scaffold; 4) New tissue organization; 5) Engineered construct transplantation. 
 
Another still less common strategy is to use scaffolds alone, implanted directly to the injured 
site without cell expansion in vitro. In this way scaffold by its own acts as a template for new 
tissue formation [30]. Currently, by TE is possible to fabricate new tissues starting from 
scaffolds, cells and biologically active molecules. Nonetheless, to achieve both functional and 
biomechanical stability as well as vascularization in laboratory-grown tissues destined for 
transplantation is a huge challenge in the field. Only a few engineered tissues have been 
approved by the Food and Drug Administration (FDA) and around 600 million dollars are spent 
every year on new products development. Examples of engineered tissues include artificial skin, 
cartilage, bone, blood vessels, artificial pancreas and artificial liver [36]. 
 Cartilage tissue engineering focused on developing in vitro tissue-materials constructs 
which can mechanically and biologically mimic cartilage tissue supporting the load applied to 
the joint. Recent approaches combine scaffolds with microfracture or drilling techniques in 
order to recruit stem cells from the subchondral bone, which together with scaffold 
implantation, guide the formation of new tissue. The main challenges in cartilage TE is to 
reduce the development of mature cartilage which normally in human lasts 18 years to a short 
time around 1-2 months of culture in vitro before implantation [10]. Moreover, to obtain 
biologically and structurally functional tissue which exhibits mechanical stability as native 
cartilage is still an issue for scientists nowadays. In the following section tissue engineering 
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approaches based on different type of cells, will be briefly described and afterwards scaffolds 
in tissue engineering will be broadly discussed.  
 
3.2. Cell sources in tissue engineering  
 Currently, cells became the important link of TE to treat cartilage lesions. Cell-scaffold 
combinations are the most used treatment approach in preclinical and clinical research for 
cartilage TE. The suitable cell source should have high proliferative potential by its own or 
should be easily expanded in vitro with capacity to produce abundant cartilage ECM 
components and maintain chondrogenic phenotype without induction of any immunological 
reaction. Autologous chondrocytes seem to be good choice according to this purpose and in fact 
there are the most common cell source in clinical studies however, articular chondrocytes have 
some limitations [37]. As has been mentioned in previous chapters low numbers of these cells 
obtained when performing the biopsy, requires expansion in vitro. Nevertheless, in 2D culture 
chondrocytes undergo de-differentiation therefore specific culture conditions as for instance, 
serum-free medium, culture in bioreactors or addition on growth factors are necessary [38]. 
Despite presented limitations, expanded autologous chondrocytes, existing under the product 
name of Carticel® are the only one approved by FDA method for cartilage TE in US [10], [30].  
 Recently, extensive attention has been addressed to mesenchymal stem cells (MSCs), 
multipotent cells which have high capacity for self-renewal and potential for differentiation into 
multiple musculoskeletal lineages such as chondrocytes, myocytes, adipocytes, osteoblasts and 
tenocyte [12]. Figure 1.4 illustrates multipotency of MSCs. MSCs can migrate toward damaged 
site of the tissue and manifest so called trophic effects which are expressed as synthesis of 
proliferative, pro-angiogenic and regenerative molecules. In addition, immunomodulatory 
action of MSCs allows for the allo- and xenotransplantation. MSCs when expanded in vitro can 
proliferate and sustain their multipotency which make them more beneficial than chondrocytes 
[39]. Very popular in the preclinical and clinical settings are bone marrow mesenchymal stem 
cells (BMSCs), used also in a form of bone marrow concentrate (BMC) [40] . BMSCs can be 
relatively easy harvested from the iliac crest and have good chondrogenic potential. Many 
studies, including randomized controlled trials (RCTs) performed by Vega or Wong showed 
positive impact of BMSCs on treatment of knee osteoarthritis [41], [42]. Nevertheless, BMSCs 
have also some disadvantages related to the cell harvest and culture therefore, other sources of 
MSCs have been investigated as adipose-derived mesenchymal stem cells (ADSCs), stem cells 
from synovial tissue (SDSCs) or from peripheral blood (PBSCs) [43]. ADSCs showed to have 
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lower chondrogenic potential than BMSCs however, their abundance and easy way to extract 
(from adipose tissue by liposuction) make them also an attractive source for cartilage TE [26].   
 MSCs exhibit excellent candidate for cell therapies however, MSC research has still a lot 
of drawbacks related to the best source, dosage, form of administration (concentrated or 
expanded), delivery and so on. Even the characterization of MSCs has not been completed yet 
due to expression of numerous different markers [44]. Alternative to MSCs can be 
chondroprogenitor cells which have recently demonstrated their chondrogenic potential even 
they do not express multipotent character. Use of chondroprogenitor cells can solve the problem 
of de-differentiation as has been already shown by several studies [45].  
 Another promising cell source for cartilage TE can be definitely embryonic stem cells 
(ESCs). ESCs has pluripotent character which means they can differentiate into any cell type 
and furthermore, ESCs have unlimited proliferation capacity. In vitro and in vivo studies have 
proved chondrogenic potential of ESCs by support of growth factors or co-culture with primary 
chondrocytes [46]. Even though, ESCs seem to be attractive alternative to other cell sources, 
their mechanism of action and regenerative potential is still not complete understood. Errors in 
ESCs differentiation could led to teratoma when some other than desired cell types are formed. 
Besides, allogenic nature can cause immuno-rejection in potential clinical application. Finally, 
there are serious ethical concerns according to use of ESCs [9].  
 
 
Fig. 1.4 Multilineage differentiation potential of mesenchymal stem cells. Adapted from 
www.mimeresearch.com. 
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4. Scaffolds for tissue engineering  
 
 Biomaterials are the crucial components of tissue engineering and they have been deeply 
studied for repair cartilage defects. The goal in the TE field is to design and fabricate biomimetic 
scaffolds [47]. Biomimicry means that scaffold by its chemical composition and 3D architecture 
can mimic native tissue allowing for tissue regeneration. Such a biomimetic scaffold should 
possess several essential features:  
a)  Should be biocompatible to promote cell attachment, cell growth, tissue integration and 
minimize immunological response of surrounding tissue;  
b)  Should be biodegradable with a suitable degradation rate which matches with the new 
tissue formation; 
c)  Should have porous microstructure with sufficient porosity, pores interconnectivity and 
pore size suitable for cell migration and transport of nutrients and waste removal; 
d)  Should create appropriate mechanical support for neotissue under native mechanical 
loads [32].  
Providing all these features when fabricating scaffolds is extremely difficult. Firstly, the choice 
of suitable biocompatible material for scaffold preparation, secondly tuning the scaffolds to 
obtain appropriate degradation rate are essential. Then the 3D architecture with interconnected 
porous structure which can facilitate cell colonization and further vascularization in vivo 
without hindering mechanical properties are important aspects [48]. Many scaffolds produced 
have desired architecture however their high porosity refereeing to little amount of material in 
the scaffold which means low stiffness and weak mechanical stability. Very often scaffolds 
have potential in vitro for good interaction with cells and for promotion ECM but they fail when 
considering in vivo application due to compromised mechanical properties. Especially in 
cartilage TE scaffolds which will be able to resistant weight-bearing area are of a great 
importance in the field [4]. Another important factor for scaffold design and fabrication is the 
cost and accessibility. In order to possess translation from the laboratory to the clinics cost 
effective production of materials should be able to scale-up according to good manufacturing 
practice (GMP) [49]. Scaffolds should be also easy to handle by clinicians and reduction of for 
harvesting autologous tissue resulting in one-step procedure without cell expansion in vitro 
would be an ideal situation.   
 Among great choice of materials available, scaffolds can be fabricated from natural or 
synthetic polymers. Natural polymers used in TE include but there are not limited to collagen, 
gelatin, hyaluronan, agarose, alginate, chitosan and silk. Polymers can have protein as collagen 
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and gelatin or polysaccharide origin as agarose and hyaluronan [2], [50]. From the protein 
polymers, collagen and gelatin are very common biomaterials and have shown efficiency as a 
scaffold for cartilage TE which will be described on the next section in this chapter.  
 Polysaccharide-based scaffolds demonstrated promotion of chondrogenesis and articular 
cartilage formation. Scaffold made from hyaluronan named as Hyaff-11 showed good 
performance in cartilage regeneration in vivo when seeded before with autologous chondrocytes 
as was reported by Grigolo et al [51]. Moreover, agarose and alginate both derived from marine 
algae were used in many studies regarding cartilage TE showing promising results in cell 
encapsulation and in support of collagen II and aggrecan production [10]. Nonetheless, alginate 
and agarose can degrade easily and they have poor mechanical properties. Other 
polysaccharides as cellulose and chitosan are also used by scientist to produce 3D scaffolds 
herein, chitosan is usually used as a blend with other polymers [50].  
 Natural polymers are promising source for 3D scaffolds preparation because of their 
composition containing specific chemical groups (ligands) which attract cells to attach and 
spread on their surface. Thus, constructs with natural origin proved to be in general 
biocompatible and capable to facilitate chondrogenesis. On the other hand, usually weak 
mechanical properties and fast in particular enzymatic degradation are limitation to their use. 
Processing these type of scaffolds to desired shape and reproducibility among different batches 
can also create difficulties [47].  
 Inversely, synthetic materials are easy to process and tailored to obtain desired structure 
good mechanical properties and optimal degradation rate. However, their lack of bioactive 
molecule and hydrophobic character which are unlikely to promote cell adhesion and 
proliferation are the drawbacks of their use [32]. The most popular synthetic polymers for TE 
application are poly lactic acid (PLA), poly-glycolic acid (PGA), PGA/PLA copolymers, 
biodegradable polyurethanes (PUR) and poly ethylene glycol [10]. An example of studies with 
such materials is chondrocyte/PGA/bioreactor system which showed enhanced chondrogenesis 
up to 40 days of culture [52]. PLA scaffold also reported satisfactory results concerning 
complete degradation after suitable time and neo cartilage tissue formation when implanted in 
mice [53]. Due to some limitations of use synthetic-based scaffolds, the trend is to combine 
synthetic and natural materials to balance their advantages and disadvantages.  
 There are a few commercially available scaffolds used for cartilage TE in Europe which 
have already brought satisfactory results in clinics. The first example is MaioRegen™ 
(Finceramica, Italy), a nanostructured scaffold consisting of different ratios of collagen and 
hydroxyapatite organized in three-layers to mimic native cartilage. Clinical trial with 27 
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patients and 5 years follow-up proved safety and good clinical outcome with stable results at 
midterm follow-up [54]. Other examples of 3D materials used for treatment of cartilage defects 
are Agili-C™ (CartiHeal Ltd, Israel) and TruFit™ (Smith & Nephew, Andover, MA). The first 
is made of coralline aragonite and the second  is a bilayer scaffold made of a semiporous 75:25 
PLGA-PGA calcium sulfate biopolymer [55]. Trufit showed some favorable results in clinics, 
however a number of studies found poor osseous integration coupled with a long time to resorb 
[56]. Agili-C manifested its potential in a caprine osteochondral defect model and the clinical 
studies concerning this implant are still ongoing [57], [58].  
 
4.1. Natural polymers 
4.1.1. Collagen  
 Collagen belongs to comprehensive family of structural protein very abundant in animals 
[59], [60]. Collagen II is a main protein component of articular cartilage as was described earlier 
[17]. Many advantages of collagen correlated to its natural character make this material broadly 
used in producing scaffolds for cartilage TE. Due to presence of collagen in native tissue, the 
surface of collagen scaffolds with biological ligands can be recognized by the cells, facilitating 
cell adhesion [50], [61], [62]. Indeed, collagen possesses in its structure repeatable motif of the 
tripeptide Arg-Gly-Asp (RGD) which is responsible for cell attachment but also overall cell 
behavior as RGD motif is recognized by cell’s integrins [63]. Integrins are transmembrane 
receptors which initiate many cellular processes as cell spreading, motility and differentiation 
[63], [64]. Additionally low-antigenicity makes collagen an attractive candidate for 
development 3D porous scaffolds in cartilage regeneration [50]. Apart from biomedical 
application collagen has been used in cosmetics, nanotechnology, nanobiotechnology, 
pharmacology, and food industries [65], [66].  
 Collagen can be processed in the three ways. The first one include the use of collagen-rich 
tissues which serve as an implant to damaged tissues after special chemical treatment. The 
second one is based on extraction of collagen from animal (e.g. bovine, porcine and equine) or 
human sources (cadavers, placenta or amnion) and its subsequent purification and 
polymerization. In addition, collagen can be also produced by use of recombinant genetic 
engineering techniques however, they are still limited [65], [66]. This polymeric protein is 
mainly used in the form of native soluble collagen, enzymatically processed native collagen 
and soluble collagen of reconstituted fibers [60].  
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 From entire collagen family, type I collagen (collagen I) is the most abundant and thus, it 
is very common in synthetizing the scaffolds. Collagen I can be extracted from dermis, bone, 
tendon and ligament [19]. Collagen I, II and XI have capacity to form fibers from a single 
collagen molecule called tropocollagen. Tropocollagen in collagen I consists of two α1 and one 
α2 peptide chains that together create 300 nm long and 1.5 nm thick triple-helix which is 
stabilized by many hydrogen bonds [67]. In each of peptide chain repeating sequence of amino 
acids can be found as follow: Gly-Pro-X or Gly-X-Hyp, where X may be any of various other 
amino acid residues. Five units of tropocollagen forms supermolecular structure referred as 
microfibril which possesses so-called D-banding pattern of 67 nm [68]. Around 500 fibrils can 
aggregate into fibre with a diameter lower than 500 nm and a length lower than 1 cm. Finally, 
the fibers form fiber bundles with a thickness between 10 and 100 mm [67], [68]. 
 
Fig. 1.5 Collagen assembly in vivo and fibers organization. Several different steps are 
presented: (a) Formation of collagen molecule (tropocollagen) from collagen precursor 
(procollagen), (b) Association of tropocollagen into collagen fibrils and their aggregation into 
larger fibers by crosslinking mechanism. At the end, fibers formed fiber bundle of a thickness 
10 - 100 mm. The illustration is adapted from www.mun.ca.  
 
This well-organized structure can be maintained thanks to crosslinking bonds created among 
collagen molecules. In physiological conditions cells must first synthesize a precursor of 
collagen, procollagen which is enzymatically processed giving rise to a tropocollagen molecule 
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[10]. Collagen self-assembly is a spontaneous and thermally driven reaction which in laboratory 
conditions can be obtained at pH range from 5.0 to 8.5, ionic strength between 0.1 and 0.8, and 
temperatures between 15 and 37˚C [66].  
In literature collagen I based scaffolds demonstrated so far promising results in promotion of 
large amount of collagen II and GAGs as well as chondrocytes proliferation and cartilage tissue 
formation [69] [70]. Nevertheless, I cannot omit a few disadvantages in usage of collagen as a 
biomaterial in TE. First of all, collagen can easily undergoes enzymatic reaction which leads to 
fast biodegradation in vivo [2]. Moreover, low tensile and compressive properties results in poor 
resistance to mechanical load [50]. To improve structural integrity, biostability and mechanical 
properties variety number of methods has been applied to reinforce collagen. These methods of 
reinforcement (crosslinking) are reported in details in the next chapter. 
 
4.1.2. Gelatin 
 Another broadly used material in TE is gelatin: thermally denatured form of collagen 
therefore, gelatin can perfectly serve as a collagen’s substitute [70]–[72]. Gelatin derives from 
animal collagen by acid (gelatin type A) or alkaline (gelatin type B) hydrolysis [72]. Similarly 
to collagen, gelatin is composed of amino acids, it contains the same amino acid motif, RGD 
which in gelatin structure may be more exposed than in collagen due to partial denaturation 
[63]. RGD motif can modulate cell adhesion and overall biological response which contributes 
to gelatin biocompatibility [64], [73]. Moreover, gelatin is biodegradable, does not exhibit 
antigenicity in physiological condition and has significant economic value hence is mainly used 
in food manufacture [74]–[77]. In TE, her low cost, simple preparation and feasible modifying 
of physicochemical properties can make gelatin even more attractive polymer than collagen to 
synthesise 3D scaffolds.  
 During denaturation process, collagen loses its triple-helix structure and takes a form of 
random coils becoming a gelatin [78]. At temperature of around 40˚C gelatin is an aqueous 
solution in the sol state and when the temperature drops down starts to turn into gel. This sol-
gel transformation occurs due to conformational changes of the gelatin chains. Upon this 
disorder-order transition of gelatin thermo-reversible network is created by associating helices 
stabilized by hydrogen bonds [74], [79]. The transformation of gelatin from sol to gel makes 
the fabrication of gelatin scaffolds apparently simple and it provides the opportunity to easily 
modulate shape of the scaffold.  
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Although there are numbers of benefits in using gelatin as an biomaterial for TE its fast 
dissolution in aqueous environment and weak mechanical properties need to be overcome, the 
same as in producing collagen scaffolds, by crosslinking. In contrast to collagen which as soon 
as is in fibrous form is resistant to degradation in aqueous solutions, gelatin represents very 
high solubility in certain temperature [67], [75].  
So far, gelatin hydrogels and gelatin porous scaffolds have been deeply studied for different TE 
approaches. For instance, after 30 days of culture with primary chondrocytes on freeze-dried 
gelatin scaffolds a tissue with a cell distribution resembling that of the native cartilage was 
developed [76]. Gelatin hydrogels are also often used in cartilage research as a material for cell 
encapsulation which can be further implanted to the defects [80], [81].  
 
Fig. 1.6 Process of collagen denaturation into gelatin. Triple-helix structure of collagen under 
denaturation changes a form to the random coils.   
 
 
4.2. Crosslinking treatment  
 Crosslinking is a general term to name creation of bonds between two polymer chains. The 
bonds can be covalent or ionic [82]. Crosslinking is used in both synthetic polymer chemistry 
and in the biological sciences. Although the term is equal for these two areas, crosslinking 
agents (crosslinker) as well as the extent, mechanism and final effect of crosslinking can vary 
[83]. Crosslinking is also a natural process occurs in the body, in which bonds are formed 
between proteins, i.e., crosslinking of native collagen leads to tissue stiffening and ageing [84]. 
In tissue engineering crosslinking refers to a method by which biomaterial is reinforced as its 
physical properties are changed upon crosslinking [47]. The reinforcement can aim at resistance 
to degradation or/and improvement of mechanical properties. Therefore, the idea of 
crosslinking is to obtain biologically and mechanically stable biomaterial which can be 
implanted in vivo and fulfill its function in tissue regeneration. The amount of crosslinking 
agents has to be always well optimize to do not create any toxic effects to the cells [59]. 
Moreover, crosslinking treatment should be easy accessible to perform, time-consuming and 
ideally it should have low cost. Apart from reinforcement crosslinking treatment can influence 
hydrophilicity, microstructure, thermal behavior of the material and also cellular response in 
22 
 
vitro [50]. Plenty of crosslinking methods have been applied in TE, as ionic, thermal, photo-
crosslinking, chemical, natural, enzymatic and non-enzymatic crosslinking [85]. Every of them 
can be appropriate depending on the type of material and application. The trend in the scientific 
world goes towards improving the crosslinking processes and finding better functioning, 
completely anti-toxic and cheap crosslinkers. This chapter focused on a few crosslinking 
treatments which are described below.  
 
4.2.1. Physical crosslinking (DHT) 
 The physical crosslinking is a traditional reinforcement method which includes 
dehydrothermal (DHT), ultraviolet (UV), and gamma irradiation treatment [85]. DHT is a 
method which involves subjecting a material to high temperature (> 90˚C) under the vacuum. 
This procedure removes water from polymer molecules and intermolecular, covalent bonds are 
formed through condensation reactions which can be esterification or amide formation [86].  
In native conditions two types of crosslinks can be generated in protein polymer as collagen 
based on the aldehyde groups formed from (hydroxy) lysine residues in the telopeptides. First, 
is an intramolecular crosslink which occurs within the same protein molecule by an aldol 
condensation reaction of two aldehyde groups. Second is an intermolecular crosslink where the 
bond is created between two adjacent molecules. The aldehyde group of one molecule reacts 
with the amino group of an (hydroxy)lysine residue of an another molecule, yielding an 
aldimine or a Schiff base [60]. In gelatin chains, upon DHT crosslinking the intermolecular 
bridges are formed between amine and carboxyl group of two adjacent molecules. It has been 
reported that DHT treatment can be effective only when amino and carboxyl group are 
sufficiently close to each other [87].  
 DHT is common method used in TE approaches as it has no toxic effects and application 
of high temperature serves also as an sterilization of materials [88]. Using either of too high 
temperature or too long time of treatment can cause degradation of gelatin molecule. On the 
other hand, denaturation may reduce the inflammation response in vivo and expose specific 
receptor sites to attract the cells [86], [89]. Complete removing of water from the polymer can 
result in lower hydrophilicity of scaffold and less surface energy available for crosslinking. In 
literature different conditions of  DHT crosslinking can be found, mostly agreeing that longer 
treatment and higher temperature (even up to 180˚C) can positively influence mechanical 
strength and crosslinking extent but also increase denaturation of protein [86], [88], [90].  
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4.2.2. Chemical crosslinking 
 Variety of chemical crosslinker has been used in stabilization of biomaterials. The most 
popular groups include: carbodiimide, glutaraldehyde, epoxy compounds and acyl azide [91]–
[94]. The mechanism of crosslinking can be different for each compound however, the main 
principle which is creating intra- and intermolecular bonds within polymer structure is 
preserved. Chemical crosslinkers are able to crosslink polymers in a higher extent than physical 
methods that is correlated to capability of reaction with more functional side group. 
 Glutaraldehyde (GTA) demonstrates the highest crosslinking degree however, the reaction 
mechanism is very complex due to the fact that aqueous solutions of glutaraldehyde contain a 
mixture of free aldehyde and mono- and dihydrated glutaraldehyde and monomeric and 
polymeric hemiacetals [60], [95], [96]. In general, the reaction involves aldehydes which react 
with the amine groups of (hydroxy)lysine residues of the protein, yielding a Schiff base which 
can be stabilized by a reduction reaction [60]. The limitation of GTA, as well as other chemical 
crosslinkers is that the unreacted compounds can lead to cytotoxicity [62], [76].  
 Carbodiimides are another group of chemical crosslinkers in which the water-soluble 
carbodiimide 1-ethyl-3-(3-dimethyl aminopropyl)carbodiimide (EDC) is commonly used for 
stabilization of collagen and gelatin. The crosslinks occur between carboxylic acid and amine 
groups and EDC by itself is not incorporated [97].  
 
Fig. 1.7 (A) Scheme of crosslinking mechanism of protein molecule by epoxy compounds: 
BDDGE and EDC/NHS coupling [98]. (B) Some crosslinking agents represented with their 
chemical formula. Adapted from www.wikipedia.org.  
 
 Epoxy compounds are of our interest in this work and one of their representative is 1,4-
butanediol diglycidyl ether (BDDGE). BDDGE is a bi-functional epoxy compound which is 
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active to react at basic pH [93], [98]. BDDGE has highly strained three-membered ring, 
susceptible to a nucleophilic attack. The mechanism of crosslinking encompasses the reaction 
with the amine groups of (hydroxy)lysine residues and the reaction with the secondary amine 
groups of histidine. In addition, this chemical can also react with the carboxylic acid groups of 
aspartic and glutamic acid showing its versatility among crosslinkers [98], [99]. BDDGE has 
not been yet properly explored in the field of tissue engineering, nonetheless its functionality 
was reported i.e., to improve the elasticity and tensile strength of the collagen implants [98], to 
develop poly(γ-glutamic) hydrogel [100] or to stabilize hyaluronic acid sponges [99]. 
 
 
4.2.3. Natural crosslinking (genipin) 
 Genipin is a naturally existing crosslinking agent derived from geniposide which is 
extracted from the fruit of Gardenia jasminoides [101]. Genipin and its related iridoid 
glucosides have been broadly used in herbal medicine [102]. In TE genipin became one of the 
first choice crosslinkers considering its lower cytotoxicity compared to chemical compounds 
[78]. During crosslinking reaction with proteins genipin releases dark blue pigment used in the 
fabrication of food dyes. Mechanism of crosslinking based on two reactions with genipin 
molecule [77]. Firstly, by nucleophilic attack of the genipin on primary amine group and 
intermediate aldehyde is formed. Then, secondary amine reacts with that aldehyde group which 
results in generation of heterocyclic compound. At final step, ester group on protein molecule 
is replaced by a secondary amide bond [77]. Amino acids of protein employed in this reaction 
are mostly lysine, hydroxyl(lysine) and arginine residues [85]. It has been demonstrated that 
genipin is even 10000 times less cytotoxic than GTA and by this reason, genipin has been 
applied to microcapsules for drug delivery [103] or used in nerve guiding conduits [104] and 
of course to crosslink scaffolds for articular cartilage engineering [76].  
 
4.2.4. Non-enzymatic crosslinking by glycation 
 Among large group of chemical crosslinkers and physical methods non-enzymatic 
crosslinking by glycation is an unconventional method which has not been particularly used in 
the scaffolds fabrication. The term glycation refers to ability of reducing sugars as 
monosaccharides (glucose, fructose, galactose, ribose, arabinose) to create covalent bonds of 
protein or lipid molecules [105]. In physiological conditions, collagen undergoes mainly 
enzymatic crosslinking by the enzyme lysyl oxidase, yielding intra- and intermolecular links 
between single molecules. Nonetheless, alternative pathway of collagen crosslinking in vivo as 
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non-enzymatic process also exists [60]. Research towards glycation of collagen has been mostly 
performed regarding diabetes and aging [84], [106]. Stiffening of proteins by crosslinking is a 
part of aging process of the ECM components in connective tissues. Moreover, in diabetes high 
amount of glucose in the blood results in the glycation of long-lived proteins as collagen [106], 
[107]. Glycation contributes to the formation of heterogeneous complex of fluorophores and 
chromophores collectively referred to as advanced glycation end products (AGEs) which can 
cause protein oxidation, impairing their overall function [107]. It has been found that AGEs are 
associated with delayed wound healing in diabetes and other degenerative diseases such as 
Alzheimer and cardiovascular disease [107], [108].  
 The mechanism of glycation begins from so-called Maillard reaction in which the aldehyde 
group of reducing sugar reacts with amino group of collagen amino acid residue producing a 
Schiff base [109], [110]. The Schiff base undergoes Amadori rearrangements to form stable 
Amadori products which, subsequently are converted to AGEs. Consequently, intermolecular 
crosslink is generated between lysine residue of collagen molecule and an arginine residue of 
another adjacent collagen molecule [111].  
 Very little is known about non-enzymatic crosslinking in the field of cartilage or bone tissue 
engineering. Primarily glycation has been investigated for skin and blood vessel substitutes 
[112], [113]. Several studies showed positive effect of glycation on decreasing degradation rate 
of native collagen and also on collagen gels [109], [113], [114]. Additionally, long-lasting 
efficiency of glycation by ribose used in dermal filler has been confirmed in a rabbit model 
[105]. Concerning cartilage TE Roy et al. reported improvement in viscoelastic properties and 
GAG release in glycated collagen compared to untreated sample [115].  
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PART II 
ANALYTICAL METHODS 
 
 
1. Freeze-drying process 
 Variety of techniques have been applied to fabricate scaffolds from synthetic and natural 
biomaterials which include conventional methods as solvent-casting and particulate leaching, 
gas foaming, phase separation, melt molding, and freeze drying. There are also other more 
advanced techniques as electrospinning and rapid prototyping which includes stereolithography 
(SLA), selective laser sintering (SLS), fused deposition modeling (FDM), three dimensional 
(3D) printing, and 3D plotting [1], [2].  
In the research of this PhD thesis freeze-drying (FD), i.e., lyophilisation method was used to 
produce 3D porous scaffolds from the natural polymers. FD process is consistent of three main 
steps: 1) Freezing at low temperature (usually in the range from –40 ˚C to –80 ˚C) where the 
polymer solution is completely frozen and the solvent forms ice crystals, forcing the polymer 
molecules to aggregate into the interstitial spaces; 2) Primary drying, where the solvent is 
removed by direct sublimation thanks to applying very low pressure through a partial vacuum; 
3) Secondary drying, where the unfrozen water molecules are removed by desorption and the 
final product in a form of dry polymer scaffold is obtained. Whereas, porosity of the scaffold 
depends on the concentration of the polymer solution, pore size distribution can be controlled 
by the freezing temperatures [3], [4]. The main advantage of FD method is the exclusion of 
many washing steps because water as well as polymer solvent can be removed directly [2]. 
Moreover, special organic and sometimes toxic solvents are not necessary which makes 
scaffolds more suitable for biomedical application. Finally, this technique can be also applied 
to dry biological samples without destroying their bioactivity. Nonetheless, there are difficulties 
to achieve scaffold homogeneity or scaffolds with hierarchical structures, e.g., vascularized 
systems, by FD [3].  
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Fig. 2.1 Steps of the freeze-drying process and its principle; a polymer solution is cooled down, 
forming solvent ice crystals. Then the solvent is removed by using a pressure lower than the 
equilibrium vapor pressure of the solvent (P° solution), giving a porous structure [1]. 
 
2. Microscopy  
2.1.  Scanning electron microscopy (SEM) 
 The principle of scanning electron microscopy (SEM) is to use a focused beam of high-
energy electrons to generate a variety of signals at the surface of solid specimens resulting in 
capture of various images. The interaction between electrons and the sample deliver 
information about the sample including external morphology (texture), chemical composition, 
and crystalline structure. SEM allows to capture high-resolution images of a sample surface, 
with the area ranging from approximately 1 cm to 5 microns in width (magnification ranging 
from 20X to approximately 30,000X, spatial resolution of 50 to 100 nm) [5].  
The signals result from interactions of the electron beam with atoms at various depths within 
the sample include secondary electrons (that produce SEM images), back-scattered electrons 
(BSE), diffracted back-scattered electrons (EBSD that are used to determine crystal structures 
and orientations of minerals), photons (characteristic X-rays that are used for elemental analysis 
and continuum X-rays), visible light (cathodoluminescence–CL), and heat. Both secondary 
electrons and back-scattered electrons are the most common in samples imaging. Secondary 
electrons play important role in illustrating morphology and topography of samples and back-
scattered electrons can provide information about the distribution of different elements in the 
sample. Characteristic X-rays are emitted when the electron beam removes an inner shell 
electron from the sample, causing a higher-energy electron to fill the shell and release energy. 
These characteristic X-rays are used to identify the composition and measure the abundance of 
elements in the sample [6], [7].  
In a typical SEM, an electron beam is thermionically emitted from an electron gun fitted with 
a tungsten filament cathode. Electron gun guides the accelerated electron beam of energy 
ranging from 0.2 keV to 40 keV toward anode. Then, the beam passes through pairs of scanning 
coils or pairs of deflector plates in the electron column and the beam is inverted horizontally 
34 
 
and vertically and it is able to scan over a rectangular area of the sample surface. During the 
interaction of primary electrons with the sample, the electrons lose energy by repeated random 
scattering and absorption within so-called interaction volume of the specimen (dimension of 
teardrop) which extends from less than 100 nm to approximately 5 µm into the surface. This 
energy exchange between the electron beam and the sample results in the reflection of high-
energy electrons, emission of secondary electrons and the emission of electromagnetic radiation 
by different scatterings, each of which can be detected by specialized detectors. The final image 
can be generated due to the fact that each pixel of computer video memory is synchronized with 
the position of the beam on the specimen in the microscope, and the concluding image is 
therefore a distribution map of the intensity of the signal being emitted from the scanned area 
of the specimen [6], [8].  
To prepare the sample for the SEM examination, a specimen has to be electrically conducting 
to obtain a sharp picture. Conductivity can be achieved by sample’s coating in gold in sputter 
coater under a vacuum [5], [8]. The microscope employed in this study was a high resolution 
SEM FEI Quanta 200, UK.  
 
Fig. 2.2 Scheme of Scanning Electron Microscope. 
 
2.2. Fluorescence microscopy 
 Fluorescence microscopy is an indispensable tool in biomedical research nowadays which 
revolutionized optical microscopy and expanded possibilities in science. The principles of 
fluorescence microscopy are derived from fluorescence and phosphorescence which are both 
types of luminescence [9]. Molecules with fluorescent properties, means those which possess 
fluorophores or exhibit autofluorescence, absorb the light with short wavelength (for example 
UV light) invisible to the human eye and then they emit the light in the visible region, with long 
wavelength and low energy. These two processes are called excitation and emission and are 
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strictly related to the energy levels of the electrons in the atomic structure of fluorescent 
specimen. A range of wavelengths of light can excite the electrons of a fluorophore resulting in 
the emission spectrum shifted to longer wavelengths which is known as Stokes' shift (Fig. 2.3) 
[9], [10]. As Stokes' shift values increase, it becomes easier to separate excitation from emission 
light through the use of fluorescence filter combinations. In immunofluorescence a single 
wavelength can be used to excite several fluorophores with different Stokes shifts and thereby 
produce a variety of fluorescence colours [11].   
 
Fig. 2.3. Schematic example of excitation and emission spectrum with well notable Stoke shift 
of a fluorescent specimen. Adapted from www.physicsforums.com 
 
In the fluorescence the essential role play already mentioned chemical compounds with 
fluorescence properties so-called fluorophores or fluorochromes. The application of 
fluorochromes allows to identify cells and sub-microscopic cellular components with a high 
degree of specificity among non-fluorescing material [12]. Fluorochromes are stains that attach 
themselves to visible or sub-visible structures, are often highly specific in their attachment 
targeting, and have a significant quantum yield (the ratio of photon absorption to emission). In 
immunofluorescence fluorochromes can be attached to antibodies which will then bind to 
specific chemical structures on or inside cells. The widespread growth in the utilization of 
fluorescence microscopy is closely linked to the development of new synthetic and naturally 
occurring fluorophores with known intensity profiles of excitation and emission, along with 
well-understood biological targets. The examples of fluorophores widely used in research are 
Hoechst 33342 or DAPI which bind to DNA, fluorescein isothiocyanate (FITC) and 
tetramethylrhodamine (TRITC) which can be conjugated with antibodies or other compounds 
[12].  
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 The majority of fluorescence microscopes, especially those used in the life sciences, are of 
the epifluorescence design where excitation of the fluorophore and detection of the fluorescence 
are done through the same light path, i.e. through the objective (Fig. 2.4). Typical components 
of a fluorescence microscope are a light source, the excitation filter, the dichroic mirror (or 
dichroic beamsplitter), and the emission filter [13]. The filters and the dichroic mirror are 
chosen to match the spectral excitation and emission characteristics of the fluorophore used to 
label the specimen. In this manner, the distribution of a single fluorophore (color) is imaged at 
a time. In epifluorescence microscope light of the excitation wavelength is focused on the 
specimen through the objective lens. The fluorescence emitted by the specimen is focused to 
the detector by the same objective that is used for the excitation which for greater resolution 
will need objective lens with higher numerical aperture. Since most of the excitation light is 
transmitted through the specimen, only reflected excitatory light reaches the objective together 
with the emitted light and the epifluorescence method therefore gives a high signal-to-noise 
ratio. An additional wavelength specific filter between the objective and the detector can filter 
out the remaining excitation light from fluorescent light. Fluorescence microscopy requires 
intense, near-monochromatic, illumination which some widespread light sources, like halogen 
lamps cannot provide. Four main types of light source are used, including xenon arc lamps or 
mercury-vapor lamps with an excitation filter, lasers, supercontinuum sources, and high-power 
LEDs [9], [13]. 
 The microscope used in this project was Eclipse Ti-U (NIKON).  
 
 
Fig. 2.4. Scheme of fluorescent microscope. Adapted from wikipedia.org. 
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3. Spectroscopy 
3.1. Ultraviolet–visible (UV-VIS) spectroscopy 
 Ultraviolet and visible spectrometers have been in general use for the last 35 years and over 
this period have become the most important analytical instrument in the modern day laboratory. 
UV-VIS spectroscopy attributes absorption and uses light in the visible and adjacent, near-UV 
and near-infrared ranges. The human eye is only sensitive to a tiny proportion of the total 
electromagnetic spectrum between approximately 380 and 780 nm and within this area the 
absorption directly affects the perceived color of the chemicals involved (Table 2.1) [14]. 
According to electronic transitions which undergo atoms and molecules in the electromagnetic 
spectrum, absorption in contrast to fluorescence, measures transitions from the ground state to 
the excited state. Molecules containing π-electrons or non-bonding electrons (n-electrons) can 
absorb the energy in the form of ultraviolet or visible light to excite these electrons to higher 
anti-bonding molecular orbitals. The more easily excited the electrons, the longer the 
wavelength of light it can absorb [15].  
 
 
 
 
 
 
 
 
Table 2.1. Relationship between light absorption and color [14]. 
UV-VIS spectroscopy is commonly used in analytical chemistry for the quantitation of different 
substances, such as metal ions, conjugated organic compounds and biological macromolecules. 
The quantification of a material (absorber) in the solution can be obtained based on Beer-
Lambert law which claims that the absorbance of a solution is directly proportional to the 
concentration of the absorbing species in the solution and the path length. To access the 
absorbance changes with concentration, it is necessary to prepare first the calibration curve by 
measuring the spectrum of a standard with a known concentration. The principle of UV-VIS 
spectrophotometer is to measure the intensity of light passing through a sample (I) and compare 
it to the intensity of light before it passes through the sample (Io).  
Color absorbed Color observed Absorbed radiation (nm) 
Violet Yellow-green 400-435 
Blue Yellow 435-480 
Green-blue Orange 480-490 
Blue-green Red 490-500 
Green Purple 500-560 
Yellow-green Violet 560-580 
Yellow Blue 580-595 
Orange Green-blue 595-605 
Red Blue-green 605-750 
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The ratio (I/Io) is called the transmittance, and is usually expressed as a percentage (%T). Then 
the absorbance A can be expressed as: A = ˗ log (%T/100%) [14], [15]. 
The basic parts of a spectrophotometer are a light source, a holder for the sample, a diffraction 
grating in a monochromator or a prism to separate the different wavelengths of light, and a 
detector. The radiation source is often a Tungsten filament (300-2500 nm), a deuterium arc 
lamp, which is continuous over the ultraviolet region (190-400 nm), Xenon arc lamp, which is 
continuous from 160-2,000 nm; or more recently, light emitting diodes (LED) for the visible 
wavelengths. Liquid samples in standard UV-VIS spectrophotometer are measured in 1 cm 
transparent cuvettes for allow the radiation to pass over the spectral region of interest. Usually, 
cuvettes are made of high quality fused silica or quartz glass (UV radiation). Normal glass and 
plastic cuvettes are also common, however glass and most plastics absorb in the UV, which 
limits their accuracy to visible wavelengths [15]. Current technology allows also for 
measurement of samples with small volumes (microplates) and moreover, absorption of many 
samples can be read at once.  
The instruments used in this study are: UV-Visible spectrophotometer (7315 Jenway, UK) and 
Multiskan FC Microplate photometer (Thermo Scientific, USA). 
 
3.2. Fourier transform infrared spectroscopy (FTIR) 
 In Fourier transform infrared spectroscopy (FTIR) an infrared spectrum (IR) of absorption 
or emission of different substances like solid, liquid or gas can be accomplished. FTIR 
spectrometer is able to simultaneously collect high spectral resolution data over a wide spectral 
range resulting in generation of spectra with patterns representing molecular structure of the 
sample. Each molecule possesses different functional groups therefore, by FTIR spectra an 
unknown sample can be identified as well as, specific impurities of the materials can be detected 
[16].  
Three different regions of infrared portion of the electromagnetic spectrum can be distinguished 
depending on their relation to the visible spectrum as follows: i) the far-IR of approximately 
400-10 cm-1 (1000-30 μm) which is positioned adjacent to the microwave region, has low 
energy and may be used for rotational spectroscopy; ii) the mid-IR, approximately 4000-400 
cm-1 (30–1.4 μm) may be used to study the fundamental vibrations and associated rotational-
vibrational structure and iii) the higher energy near-IR, approximately 14000-4000 cm-1 (1.4–
0.8 μm) can excite overtone or harmonic vibrations [16], [17].  
IR spectroscopy takes advantage of the fact that each molecule has its specific frequency at 
which it rotates or vibrates corresponding to discrete energy levels (Fig.2.5). The specific, 
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resonant frequencies are determined by the shape of the molecular potential energy surfaces, 
the masses of the atoms and, by the coupling of vibrational and electronic interactions in the 
molecule. Therefore, the resonant frequencies can be correlated to a particular bond type and 
can be used for the characterization of very complex mixtures [18]. 
 
Fig. 2.5 Possible vibrations detected by infrared spectroscopy (top of the illustration) and 
example of the corresponding FTIR spectrum [18].  
 
 In the FTIR instrument a beam of infrared light goes through an interferometer and onto 
the sample absorbing all the different wavelengths characteristic of its spectrum at once. 
Instead, in standard IR spectrometer with a monochromater the source radiation is separated 
into its different wavelengths limiting the amount of signal which can be obtained at a particular 
resolution. Thanks to the beamsplitter which send the light through moving and stationary 
mirrors the beam passing through the sample is recombined and the detector reports variation 
in energy versus time for all wavelengths simultaneously (Fig. 2.6) [17].  
 
  
Fig. 2.6 Scheme of FTIR spectrometer. Adapted from www.chemistry.oregonstate.edu [17]. 
In order to prepare sample for FTIR analysis, necessary is to grind a quantity of the sample with 
potassium bromide finely (to remove scattering effects from large crystals), which is used also 
as a reference. This powder mixture is then crushed in a mechanical die press to form a 
translucent pellet through which the beam of the spectrometer can pass. The use of reference is 
important because it can prevent fluctuations in the output of the source affecting the data and 
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also it allows the effects of the solvent to be cancelled out (the reference is usually pure solvent) 
[16].  
The equipment employed in the present work was a Thermo Nicolet-Avatar 320 FT-IR. 
 
4. Thermo-gravimetric Analysis (TGA) 
 Thermogravimetric Analysis (TGA) is a type of testing used to determine changes in weight 
depending on changes in temperature of tested samples. In TGA analysis three crucial 
parameters have to be measured accurately, which are: weight, temperature, and temperature 
change. Due to the fact that many weight loss curves look similar, the weight loss curve requires 
transformation before results may be interpreted. A derivative weight loss curve can be used to 
tell the point at which weight loss is most apparent. 
The TGA analyzer usually consists of a high-precision balance with a pan loaded with the 
sample. The sample is placed in a small electrically heated oven with a thermocouple to 
precisely measure the temperature. The atmosphere may be purged with an inert gas to prevent 
oxidation or other undesired reactions and a computer is used to control the instrument. 
Analysis is carried out by raising the temperature gradually and plotting weight against 
temperature. After the data is obtained, curve smoothing and other operations may be done such 
as to find the exact points of inflection [19].   
A Q600 instrument was used in this study (TA instruments). 
 
5. Mechanical analysis 
 Mechanical testing is a powerful analytical tool which can provide information about 
mechanical properties of the materials. Among variety of tests, mechanical analysis can be 
simply divided into two categories: static and dynamic mechanical analysis.  
 Static mechanical test is a an evaluation in which static loading (force/stress) is applied to 
the sample in order to obtain values of Young’s modulus (elastic modulus), compressive or 
tensile strength, stiffness etc. [20]. The static test can be performed in the compressive or tensile 
mode, in compression or tensile clamp respectively. The choice of the clamp depends on the 
searched information and also on the type of material testing. Gels and elastomers are suitable 
for the compression clamp while films and fibers can be measured in the tension clamp. Under 
compression a material undergoes deformation and shortening as its molecules are forced 
together. Compression or compressive strength is the capacity of a material to withstand axial 
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loads tending to reduce size, in contrast to tensile strength, which withstands loads tending to 
elongate. Suitable compressive strength is a key value for scaffolds design [20], [21].  
From the basic uniaxial mechanical test we can plot so-called stress-strain curve and based on 
this curve calculate Young’s modulus. The stress-strain curve is obtained by recording the 
amount of deformation (strain) at distinct intervals of tensile or compressive loading (stress) 
and it differs for various types of materials (Fig. 2.7). In the stress-strain curve different regions 
can be distinguished and the most important is the initial linear part where the material follows 
Hooke's Law. This linear portion of stress-strain curve is an elastic range attributing to elastic 
modulus (Young’s modulus) which refers to the measurement of the material’s stiffness, or its 
resistance to deformation. Young’s modulus (E) is the ratio of stress (σ) to strain (ε) and can be 
calculated as follows [22]:  
  
   where,       and 
 
 
 
 
 
Fig. 2.7 (A) Example of stress-strain curve and analysis of its different parts as linear and 
nonlinear region [20]. (B) Diverse stress-strain curves corresponded to different materials; 
adapted from www.che.hw.ac.uk 
 
The linear region terminates at what is known as the yield point. Above this point the material 
behaves plastically and will not return to its original length once the load is removed. At some 
load the material will fail (break), and this is known as the ultimate strength, in compression as 
the compressive strength (Fig. 2.7 A). It should be noted that this failure at the ultimate strength 
 𝐼𝑓 =
𝐹
𝐴𝑜
 𝜀 =
𝐿 − 𝐿𝑜
𝐿𝑜
 
𝐹 - is the force exerted on an object under tension, 
Ao - the actual cross-sectional area through which the force is applied, 
Lo  – original lenght of the sample, 
L – current lenght  of the sample.  
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follows massive deformation of the sample. The area under the curve is proportional to the 
energy needed to break the sample. The shape of the stress-strain curve and its area tells us 
about whether the material is tough or brittle or weak or strong. Depends on the type of material 
tested: plastic, fibre, glass or elastic polymer different Young’s modulus and different failure 
point can be observed (Fig. 2.7 B) [20].  
 
 Dynamic mechanical analysis (DMA) or dynamic mechanical thermal analysis (DMTA) 
refer to mechanical tests in which oscillating force is applying to a sample and material’s 
response is analysed to characterize its viscoelastic behaviour [23]. From this, one calculates 
properties like the tendency to flow (called viscosity) from the phase lag and the stiffness 
(modulus) from the sample recovery. These properties are often described as the ability to lose 
energy as heat (damping) and the ability to recover from deformation (elasticity).  
 
Fig. 2.8 DMA analysis: The relationship of the applied sinusoidal stress to strain with the 
resultant phase lag and deformation. Fd is the dynamic or oscillatory force while Fs is the static 
or clamping force. On the right corner: mathematical relation among complex modulus (E*), 
storage modulus (E’), loss modulus (E’’) and tan delta (δ) [20]. 
 
In DMA test a set of multiple or single frequencies can be applied to the sample as well as 
different temperature range (DMTA). The DMA supplies an oscillatory force, causing a 
sinusoidal stress to be applied to the sample, which generates a sinusoidal strain. By measuring 
both the amplitude of the deformation at the peak of the sine wave and the lag between the 
stress and strain sine waves, quantities like the modulus, the viscosity, and the damping can be 
calculated (Fig. 2.8) [20], [23]. Dynamic stress, , and strain, , are given as:  
 
 
 
 
where ω is the angular frequency. 
The modulus measured in DMA is a complex modulus (E*), calculated from the material 
response to the sine wave and composed of elastic (storage) modulus (E’) and imaginary (loss) 
 
 
43 
 
modulus (E’’) [20]. The storage modulus is an in-phase component describing the ability of the 
material to return or store energy. E’ refers to the elastic response of the material but it is not 
exactly the same as the Young’s modulus. Loss modulus is an out of phase component 
describing the loss of energy by a material and it is a measure of its viscous response. The ratio 
of storage to loss modulus is called tan delta (δ) or loss factor and it refers to damping, the 
measure of energy dissipation of a material [21]. The complex (E*), storage (E’) and loss (E’’) 
modulus as well as tan δ can be given in mathematical equations as follow:  
 
 
        and    
 
 DMA analyzers allow for performing variety of tests: dynamic oscillatory tests as 
frequency sweep or stress/strain sweep and also transient tests as creep and stress relaxation. 
Creep testing is a basic probe of polymer relaxations and a fundamental form of polymer 
behavior. Creep test involves loading a sample with a set weight and watching the strain change 
over time. Recovery tests look at how the material relaxes once the load is removed [20].  
The instrumentation of a DMA consists of a displacement sensor such as a linear variable 
differential transformer, which measures a change in voltage as a result of the instrument probe 
moving through a magnetic core, a temperature control system or furnace, a drive motor (a 
linear motor for probe loading which provides load for the applied force), a drive shaft support 
and guidance system to act as a guide for the force from the motor to the sample, and sample 
clamps in order to hold the sample being tested [24]. Geometry and dimensions of the sample 
are of the great importance when performing mechanical tests. Soft materials which were tested 
in this PhD work are suitable for use in the compressive mode as they often possess irregular 
shape and surfaces which make them more difficult to mount. Additionally, the thickness of the 
sample should be preferably higher or equal to its width.  
DMA Q800 dynamic mechanical analyzer (TA instruments, IT) was the instrument employed 
in this study.  
 
6. Quantitative real-time polymerase chain reaction (qPCR) 
A real-time polymerase chain reaction (qPCR) is a laboratory technique in molecular 
biology which allows to detect and quantify RNA. Similar to traditional PCR (end-point 
detection), the idea of qPCR is to amplify a piece of DNA across several orders of magnitude, 
generating thousands to millions of copies of a particular DNA sequence. Nevertheless, unlike 
conventional PCR, real-time PCR allows monitoring of the desired product at any time in the 
𝐸 ∗= 𝐸′ + 𝑖𝐸′′    
𝐸′ =
𝐼𝑓𝑜
𝜀𝑜
cos(𝛿) 𝐸′′ =
𝐼𝑓𝑜
𝜀𝑜
sin(𝛿) 𝑡𝑎𝑛𝛿 =
𝐸′′
𝐸′
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amplification process. For traditional PCR data is collected at the end-point (plateau), while 
real-time PCR collects data in the exponential growth phase. By using real-time PCR post PCR 
detection methods like electrophoresis in agarose, which are not precise and time consuming, 
can be avoided [25].  
Another variant of PCR is a reverse transcription PCR (RT-PCR), which can be combined with 
real-time PCR (RT-qPCR) and such a combined technique was used in this study. In RT-PCR, 
RNA is used as a template to synthesize complementary DNA (cDNA) by enzyme called 
reverse transcriptase, which further serves as the template in the real-time PCR. To obtain 
cDNA in RT reaction a few components are needed: purified extracted RNA of interest, 
deoxyribonucleotides (dNTPs) as building blocks of cDNA, reverse transcriptase, non-specific 
primers and RNase inhibitor [26].  
Two common methods for the detection of PCR products in real-time PCR are: (1) non-specific 
fluorescent dyes that intercalate with any double-stranded DNA, and (2) sequence-specific 
DNA probes consisting of oligonucleotides that are labelled with a fluorescent reporter which 
permits detection only after hybridization of the probe with its complementary sequence [27]. 
In the first option, commonly used fluorescent dye is a SYBR Green and in the second method, 
applied in the study of this thesis, is a technique with usage of TaqMan Probes. TaqMan probes 
are oligonucleotides having a fluorescent probe (reporter) attached to the 5' end and a quencher 
to the 3' end. During PCR amplification, these probes anneal to the target sequences of cDNA 
between the forward and reverse primers and as polymerase replicates the template with 
TaqMan bound, it also cleaves the fluorescent probe due to polymerase 5'- nuclease activity. 
Thereby, the distance between the reporter and the quencher increases causing the transfer of 
energy; the fluorescent emissions of the reporter increase captured by the Sequence Detection 
instrument and displayed by the software [25].  
The PCR process normally is composed of approximately 25-50 cycles and contains a few main 
steps: the first (denaturation), at around 95 °C, allows to disrupt DNA template into single-
stranded DNA molecules; the second (annealing), at a temperature of around 50-60 °C, allows 
the binding of the primers with the DNA template; the third (extension/elongation), at between 
68 - 72 °C, facilitates the polymerization carried out by the DNA polymerase [26]. 
In this work, gene expression analysis has been performed by firstly reverse transcription 
carried out at different temperature as follow:  
1) 25 °C for 10 min; 
2) 37 °C for 2 h; 
3) 85 °C for 5 min; 
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Activation of Taq 
polymerase enzyme 
4) 4°C for ∞. 
Then, qPCR (Taqman assay) could be performed using two pre-steps (1 and 2) and proper qPCR 
reaction composed of 40 cycles (Step 3 and 4): 
1) 50 °C for 2 min; 
2) 95 °C for 10 min; 
3) Denaturation at 95 °C for 15 s; 
4) Annealing/Extension at 60 °C for 1 min [25]. 
The machine for both RT and qPCR was supplied by Applied Biosytems, USA. After the 
reactions, gene expression can be analysed by absolute or relative quantitation. Absolute 
quantification relates the PCR signal to input copy number using a calibration curve, while 
relative quantification measures the relative change in mRNA expression levels correlated to 
mRNA expression of endogenous control (reference gene). Housekeeping genes e.g. 
glyceraldehyde 3-phosphate dehydrogenase or β-actin can be used as a reference gene [27].   
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PART III 
EXPERIMENTAL 
 
Chapter 1 
Experimental procedures 
 
1.1. Scaffolds Morphology Analysis  
 The morphological micro-architecture of the scaffolds was evaluated by scanning electron 
microscopy (SEM) performed on specimens mounted onto aluminium stubs using black carbon 
tapes and sputter coated with gold (Sputter Coater Q150TES, Quorum, Italy). The specimen 
surface was examined using high resolution SEM (FEI, Quanta 200, UK) at a pressure of 0.1m 
Torr at an accelerating voltage of 15 kV.  
The pore size and pore distribution in the wet scaffolds were evaluated by imaging of thin slices 
(20 μm thickness) under a bright field with inverted Ti-E fluorescence microscope (Nikon). The 
slices were obtained by using a cryostat (Histo-line, 5000 MC) to cut scaffolds previously 
soaked in phosphate buffer saline (PBS, pH 7.4) for 24 h then embedded in OCT and 
subsequently quenched into liquid nitrogen.   
 
1.2. Measurement of porosity  
 Percentage of porosity was measured by gravimetric method [1] conferring total porosity 
of the scaffold, and by water squeezing method [2] resulting in percentage of macropore 
volume. Total porosity of the scaffold was defined by measuring density of the dry scaffold 
(ρ*) and relating it to the known density of our polymers, collagen or gelatin (ρm), following 
the formula:  
 
 
where, density of the scaffold (ρ*) is the ratio between the mass and the volume of the sample.  
Porosity measured by water squeezing method was expressed as a ratio between the water 
Porosity (%) = (𝟏 −  
𝛒∗
𝛒𝐦
) × 𝟏𝟎𝟎 𝝆∗ =
𝐦𝐚𝐬𝐬
𝐯𝐨𝐥𝐮𝐦𝐞
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strongly bound by polymer and the water present in entire porous structure of the polymer. 
Samples were immersed in milli-Q water for a few hours to obtain complete swelling, weighed 
(W1), next squeezed and weighed again (W2). Percentage of macropore porosity was calculated 
by the following equation:  
 
 
For both tests three cylindrical samples (diameter: 8-9 mm, thickness: 5 mm) of each 
composition were measured.  
 
1.3. Fluid uptake 
 The swelling properties of the scaffolds were evaluated by monitoring the ability of fluid 
uptake with time. Cylindrical samples (diameter: 8-9 mm, thickness: 5 mm) were immersed in 
PBS at pH 7.4 and at 37 °C to mimic the physiological conditions. After designed soaking time 
the scaffolds were taken, wiped in filter paper and their weight was noted. The percentage of 
swelling ability was calculated by the following equation:  
𝐅𝐥𝐮𝐢𝐝 𝐮𝐩𝐭𝐚𝐤𝐞 (%) = (
𝐖𝐭 − 𝐖𝐨
𝐖𝐨
) 𝐱 𝟏𝟎𝟎 
where Wo is a dry weight of the sample and Wt is a weight after swelling. Four samples for 
each group were analysed at respective soaking times. 
 
1.4. Extent of crosslinking 
 The degree of cross-linking was quantified by 2, 4, 6-Trinitrobenzene sulfonic acid (TNBS) 
assay according to the method of Balakrishnan et al [3]. Briefly, 5 mg of crosslinked and non-
crosslinked scaffolds were immersed in aqueous solution containing 1 ml of 4% (w/v) sodium 
hydrogen carbonate and freshly prepared 0.5% (v/v) TNBS (Sigma Aldrich, USA). Next, the 
mixtures were incubated in a water bath at 40 °C for 2 h. The reaction was terminated by 
addition of 3 ml of 6 M HCl to each reaction mixture and incubated at 60 °C for 1.5 h. The 
amount of amine groups bound to TNBS in the scaffolds was assessed by measuring the 
absorbance at 415 nm wavelength using UV-Visible spectrophotometer (7315 Jenway, UK). 
Percentage of crosslinking degree was then calculated according to the formula:  
𝐂𝐫𝐨𝐬𝐬𝐥𝐢𝐧𝐤𝐢𝐧𝐠 𝐝𝐞𝐠𝐫𝐞𝐞 (%) = 𝟏 − (
𝐀𝐜𝐫𝐨𝐬𝐬𝐥𝐢𝐧𝐤𝐞𝐝
𝐀𝐧𝐨𝐧−𝐜𝐫𝐨𝐬𝐬𝐥𝐢𝐧𝐤𝐞𝐝
) 𝐱 𝟏𝟎𝟎 
where, Acrosslinked was the absorbance of crosslinked samples and Anon-crosslinked was the 
absorbance of non-crosslinked control. The experiment was performed in triplicate. 
 
𝐌𝐚𝐜𝐫𝐨𝐩𝐨𝐫𝐞 𝐩𝐨𝐫𝐨𝐬𝐢𝐭𝐲 (%) =  (
𝑾𝟏 −𝑾𝟐
𝑾𝟏
) × 𝟏𝟎𝟎 
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1.5. Degradation assays 
1.5.1. Weight loss measurements 
 The physiological stability and controlled degradability of the scaffolds were assessed by 
monitoring the degradation rate. Briefly, 5 cylindrical samples (diameter: 8 mm, thickness: 5 
mm) for each time point were immersed in PBS, pH.7.4 at 37 °C for 3, 7, 14 and 21 days. At 
scheduled time points scaffolds were rinsed two times in milli-Q water and dried at 40 °C. The 
percentage of weight loss was calculated by the following equation:  
𝐖𝐞𝐢𝐠𝐡𝐭 𝐥𝐨𝐬𝐬 (%) = (
𝐖𝐨 − 𝐖𝐝
𝐖𝐨
) 𝐱 𝟏𝟎𝟎 
where Wo is an initial dry weight and Wd is a final weight of the sample after drying.  
1.5.2. Collagenase digestion test 
 Stability of ribose-crosslinked collagen scaffolds was evaluated by in vitro enzymatic 
degradation test [4], [5]. Briefly, glycated and non-glycated collagen scaffolds of 10 mg dry 
weight were incubated in 1 ml 0.1 M Tris-HCl (pH 7.4) containing 22 CDU/mL (collagen 
digestion unit/mL) of bacterial collagenase (Clostridium histolyticum, Type 1, Sigma Aldrich, 
USA), at 37 °C. After 6 h, scaffold degradation was determined by protein quantification in the 
solution after digestion using a colorimetric assay (Kit DC Protein Assay, Bio-Rad). Percentage 
of degradation of the samples was calculated respect to the non-crosslinked collagen considered 
to be 100 % degraded. Three samples of each composition were measured.  
The time of 6 h, needed for complete non-crosslinked collagen digestion was set by preliminary 
test according to the method of Sandri et al [5]. The degradation kinetics was evaluated reading 
the absorbance at λ = 280 nm, corresponding to the absorbed wave number of the aromatic 
amino acids, Tyrosine and Tryptophan, released during the enzymatic collagen degradation. At 
different time points, percentage of digested collagen was calculated by the following equation: 
 
 
where A280(t) is an absorbance at the particular time and A280 (max) is a final absorbance of the 
sample which remains constant with increasing time.  
 
1.6. Fourier Transform Infrared Spectroscopy (FTIR) 
 The infrared spectra of scaffolds were obtained using Nicolet 380 FT-IR spectrometer 
(Thermo Fisher Scientific Inc, Waltham, USA). Initially, 2 mg of the scaffold were mixed with 
100 mg of anhydrous KBr and then pressed at 8000 psi into 7 mm diameter discs. The spectra 
were collected in the wavelength ranging from 400 to 4000 cm-1 with 2 cm-1 of resolution. 
𝐂𝐨𝐥𝐥𝐚𝐠𝐞𝐧 𝐝𝐞𝐠𝐫𝐚𝐝𝐚𝐭𝐢𝐨𝐧 (%) = (
𝐀𝟐𝟖𝟎(𝐭)
𝐀𝟐𝟖𝟎 𝐦𝐚𝐱
) × 𝟏𝟎𝟎 
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1.7. Thermal characteristics 
 The pyrolytic pattern of the scaffolds was determined using Thermo Gravimetric Analyser 
(TGA) (STA 449/C Jupiter, Netzsch Germany). Briefly, 10 mg samples were placed in 
aluminium crucible, crushed and press sealed for complete contact with the crucible. The 
experiment was carried out in the temperature range of 30–600 °C at a heating rate of  
10 °C /min in nitrogen atmosphere.  
 
1.8. Mechanical analysis 
 Both static and dynamic compression test as well as creep test were performed in the 
compressive mode using DMA Q800 dynamic mechanical analyser (TA instruments, IT). For 
each test, cylindrical samples of gelatin scaffolds (diameter: 8 mm, thickness: 5 mm) and of 
collagen scaffolds (diameter: 9 mm, thickness: 7 mm) were pre-hydrated in PBS at 37 °C for 
24 h prior to testing. Every test was carried out at 37 °C to mimic the physiological conditions. 
A small preload force was applied to each sample to provide a complete contact between the 
scaffold’s surface and the compression plates.  
1.8.1. Static compression  
 For standard mechanical evaluation samples were uniaxial compressed using Controlled-
Force DMA test with a force ramp rate of 0.5 N/min up to 2N in case of gelatin scaffolds and 
0.1 N/min up to 2 N in case of collagen scaffolds. The compressive modulus (elastic modulus) 
was calculated from the initial linear part of the obtained stress-strain curve. The test was 
repeated 5 times.  
1.8.2. Dynamic compression 
 The viscoelastic spectra of the scaffolds in the compressive mode were performed using 
Multi-Frequency DMA test with frequency scan from 0.1 until 10 Hz measurements. The 
experiment was performed under a constant strain amplitude of 75 µm. Storage modulus (E’) 
and loss factor (tan δ) were plotted on graphs. The test was repeated 5 times. 
1.8.3. Creep 
 The creep test was carried out at the constant stress 0.002 MPa based on the previous stress-
strain curves analysis.  The samples, after an isothermal period of 5 min at 37 °C, were subjected 
at the definite stress for 15 min and then left at rest for 15 min (recovery time). Strain and strain 
recovery values in the function of time were plotted on graphs. The test was repeated 3 times. 
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1.9. 3D cell culture  
 Three different cell lines were used for the experiments presented in this work. For 
expansion, cells from each cell line were cultured in standard medium supplemented with 10% 
Fetal Bovine Serum (FBS, Gibco) and 1% penicillin/streptomycin (100 U ml-1/100 µg ml-1) and 
they were incubated at 37 °C with 5% CO2 atmosphere. The cells were cultured until 80% 
confluence and detached by trypsinization and centrifugation, later the cell number and viability 
was assessed by trypan blue dye exclusion test. The media were changed every two days. All 
cell handling procedures were performed in a sterile laminar flow hood. 
a) MG-63 Human Osteosarcoma cell line were supplied by Lonza (ECACC 86051601) and 
used in preliminary cytotoxicity evaluation. Cells were cultured in Dulbecco Modified Eagle’s 
Medium (DMEM, Gibco) with supplementation as mentioned above. The experimental 
scaffolds were cut out by puncher with dimensions of 8 mm in diameter and 4 mm in thickness 
and were sterilized with two washing cycles in 70% ethanol for 10 minutes each, one washing 
cycle in 1X PBS for 10 minutes and UV exposure of each side of the scaffold for 25 minutes. 
Prior to experimentation, all scaffolds were pre-incubated with 1 ml of culture media for 1 h 
and afterwards the samples were placed one per well in a 24-well plate. Scaffolds were seeded 
by dropping 20 µl of 3.0 x 104 cells suspension in culture media onto the upper layer of the 
scaffold for initial cell attachment. After 30 min, 1.5 ml of cell culture media was added and 
incubated at 37 °C, 5% CO2 for 7 days.   
b) Human chondrocytes cell line (CHON-002) were supplied by ATCC® (CRL -2847™, 
Italy) and used to investigate the cell-scaffold interaction. The chondrocytes were cultured in 
DMEM (ATCC-30-2021) supplemented as above. Cylindrical samples of the gelatin scaffolds 
with 8 mm in diameter and 5 mm in thickness were sterilized by 25-kGy gamma-ray radiation. 
Prior to experimentation, all scaffolds were pre-washed with 50 ml of the culture media (10 
samples/falcon) gently shaking for 24 h at room temperature (RT). Samples were placed one 
per well in a 24-well plate and a drop of 20 µl containing 5.0 × 104 cells suspension in culture 
media was added onto the upper layer of the scaffold. After 30 min, 1.5 ml of cell culture media 
was added and placed in the cell incubator for 14 and 21 days (for gene expression analysis).   
c) Mouse (C57BL/6) mesenchymal stem cells (mMSCs) were supplied by GIBCO® (Thermo 
Fisher scientific) and used to investigate cellular behaviour in 3D culture with collagen 
scaffolds. For expansion, mMSCs were cultured in standard medium DMEM-F-12/Glutamax 
(Gibco) supplemented with 10% FBS (Gibco) and 1% penicillin/streptomycin as above. For the 
experiments mMSCs were cultured in chondrogenic medium High-glucose DMEM (Gibco) 
supplemented with 10 ng/ml TGF-β1 (Invitrogen), 1% ITS (Insulin-Transferrin-Selenium, 
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Gibco), 37.5 µg/ml ascorbic acid (Sigma), 10-7 M dexamethasone and 1% 
penicillin/streptomycin (100 U ml-1/100 µg ml-1). Cylindrical samples of experimental scaffolds 
with dimensions of 9 mm in diameter and 5 mm in thickness were sterilized by 25-kGy gamma-
ray radiation. Prior to experimentation, all scaffolds were pre-washed with 50 ml of the culture 
media (10 samples/falcon) gently shaking for 24 h at RT. Samples were placed one per well in 
a 24-well plate and a drop of 50 µl containing 2.0 x 105 cells suspension in culture media was 
added onto the upper layer of the scaffold for initial cell attachment. After 30 min, 1.5 ml of 
chondrogenic cell culture medium was added and incubated at 37 °C, 5% CO2 for 28 days.   
 
1.10. Cell viability  
Cell viability was assessed by Live&/Dead  assay (Invitrogen, USA) which is based on the 
simultaneous determination of live and dead cells with two probes, Calcein and Ethidium 
homodimer-1 (EthD-1), that measures the recognized parameters of cell viability: intracellular 
esterase activity and plasma membrane integrity respectively. Briefly, at specified time points 
of cell culture, depending on the experiment, cell-seeded constructs were washed in 1X PBS 
(pH 7.4) for 5 min and stained with Calcein acetoxymethyl (Calcein AM) 2 µM and Ethidium 
homodimer-1 (EthD-1) 4 µM for 15 min at 37 °C. Later the constructs were again washed in 
1X PBS for 5 min and viewed under inverted Ti-E fluorescence microscope (Nikon). In case of 
collagen scaffolds, the ratio of live/dead cells and the cell number were determined by 
quantifying the number of cells from the upper surface of the scaffold in three random fields of 
view per sample at the same magnification, using ImageJ software. Two samples per every type 
of scaffolds were analysed at each time point.  
Additionally, the nuclear morphology integrity, as index of cell viability and cell 
colonization through the scaffolds were evaluated using nuclear fluorescent dye. At individual 
time points, cell-scaffold constructs were rinsed in 1X PBS and stained with 4’,6-diamidino-2-
phenylindole (DAPI) and immediately viewed under inverted Ti-E fluorescence microscopy. 
 
1.11. Cell proliferation assay 
 At regular time intervals of 1, 3, 7 and/or 14 days of cell culture, depending on the 
experiment, 10% 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
solution of the total volume of the well was added and incubated for 2 h at 37 °C. In this assay, 
the metabolically active cells react with the tetrazolium to produce formazan crystal salts. After 
incubation, the scaffolds were transferred to centrifuge tubes and 1ml of dimethyl sulfoxide 
(DMSO) was added. The scaffolds were crushed using the pestle and vortexed subsequently to 
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release the formazan salts of the inter-located cells and incubated at RT for 15 min and 
centrifuged at 1000 rpm for 1 min. Later, 200 µl of the supernatant was transferred to 96-wells 
plate and read using a spectrophotometer (Multiskan FC Microplate photometer, Thermo 
Scientific, USA) at optical density of 570 nm. This absorbance is directly proportional to the 
number of metabolically active cells. Three cell-seeded scaffolds per time were measured. 
Acellular blank scaffolds were treated equally during the culture time and the experiment. Three 
blank samples of each type of scaffold tested were used at the individual time point and their 
absorbance values were subtracted from the cell-seeded constructs.  
 
1.12. Cell morphology 
1.12.1. Actin-phalloidin staining 
 After 3 and 7 days of cell culture, morphology of the cells grown on the scaffolds was 
evaluated by phalloidin immunofluorescence staining. Cell-seeded scaffolds were washed with 
1X PBS for 5 min, then fixed with 4% (w/v) paraformaldehyde in 1X PBS for 15 minutes and 
washed again 2 times with PBS for 5 min. Permeabilization of cell membrane was performed 
with 0.1% (v/v) Triton X-100 (Sigma-Aldrich) in PBS for 5 min. Then, FITC-conjugated 
phalloidin antibody (1:500; Invitrogen) diluted in PBS was added to the samples and incubated 
for 20 min at RT in the dark in order to visualize filamentous actin (F-actin) in the cell. After 
another washing in 1X PBS counterstaining with DAPI (1:200; Invitrogen) diluted in PBS was 
carried out for 5 min to visualize cell nuclei. Rinsed in PBS samples were mounted on the 
coverslip and viewed under inverted Ti-E fluorescence microscope (Nikon).  
1.12.2. SEM analysis 
 Scanning electron microscopy (SEM) was used to analyse morphology of the cells grown 
on the scaffolds. Briefly, after specified time, depending on the experiment, the cell-seeded 
scaffolds were washed with 0.1 M sodium cacodylate buffer (pH 7.4) and fixed in 2.5% 
glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) for 2 h at 4 °C, washed in 0.1 M 
sodium cacodylate buffer (pH 7.4) and freeze-dried. Later, the specimens were mounted onto 
the aluminium stubs using black carbon tapes and they were sputter coated with gold particles 
(Sputter Coater Q150TES, Quorum, Italy). The cells on the scaffold surface and inside the 
scaffold were then examined using high resolution SEM (FEI, Quanta 200, UK). 
 
1.13. Glycosaminoglycans (GAG) assay 
 After designed time points, the cell-seeded scaffolds and acellular scaffolds were harvested 
for sulphated glycosaminoglycan (GAG) assay. The scaffolds were treated at 65 °C for 3 h in 
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750 µl of lysis buffer consisting of Hank’s Balanced Salt Solution (HBSS, pH 6.4), 125 µg/ml 
papain, 8 mg/ml sodium acetate, 4 mg/ml EDTA and 0.8 mg/ml L-cysteine-HCl (all Sigma 
Aldrich, USA). The digestive solution was centrifuged and supernatant was collected and mixed 
with dimethylmethylene blue (DMMB) reagent (Sigma Aldrich, USA) according to the 
protocol of Richard W. Farndale et al. [6]. GAG quantification was determined by measuring 
the absorbance of DMMB bound to GAGs at ʎ 530 nm using a spectrophotometer (Multiskan 
FC Microplate photometer, Thermo Scientific, USA). Shark chondroitin sulphate (Sigma 
Aldrich, USA) with concentration gradient from 1 to 30 µg/ml was used as a standard and 
scaffolds without cells were used as blank samples. Three scaffolds were measured per each 
time point. 
 
1.14. RNA isolation and quantitative real-time polymerase chain reaction (qPCR) 
 Total RNA was isolated from the harvested cell constructs at designed time points using 
TriFast® reagent (EuroClone, USA). In brief, the samples were lysed in 1 ml of TriFast® 
reagent, crushed and centrifuged at 12,000 × g for 5 min. The collected supernatant was used 
for RNA purification based on Direct-Zol™ RNA MiniKit (Zymo Research, USA). The 
purified RNA was quantified using Qubit® RNA BR assay kit and Qubit® fluorimeter. The 
integrity of the RNA was analysed using native agarose gel electrophoresis. Reverse 
transcription was carried out on purified RNA (500 ng) to produce cDNA using high capacity 
cDNA reverse transcriptase kit with RNase inhibitor, according to manufacturer’s instructions 
(Applied Biosytems, USA). Relative quantification of gene expression, using Taqman assays 
(Applied Biosystems), for transcription factor (SOX9, HS01001343), aggrecan (ACAN, 
HS00153936) and glyceraldehyde 3-phosphate dehydrogenase, used as housekeeping gene, 
(GAPDH, HS99999905) was performed by use of the StepOne Real-Time PCR System 
(Applied Biosystems). Three technical replicates for each sample were used and data were 
collected using the OneStep Software (v.2.2.2). Relative quantification of the target gene 
expression was generated normalizing to GAPDH using the comparative threshold (Ct) method 
[7]. 
 
1.15. Western Blot analysis  
 After 7 and 14 days, cell-seeded scaffolds and acellular scaffolds used as a negative control 
were lysed in a Radioimmunoprecipitation buffer (RIPA buffer) supplemented with a 
proteinase inhibitor cocktail (Cell Signalling). Protein concentration in each supernatant of cell 
lysate and acellular scaffold lysate was determined by a colorimetric assay (Kit DC Protein 
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Assay, Bio-Rad) and the real protein concentration was obtained by subtracting concertation of 
the acellular scaffold from the cell-seeded scaffold. The final samples of concentration 15 µg/ml 
were diluted in sample loading buffer (3:1), loaded and separated in a 4–15% Mini-PROTEAN 
TGX stain-free protein gels (BioRad), using a Mini-PROTEAN electrophoresis cell kit (Bio-
Rad). The proteins were then transferred to nitrocellulose membranes by means of a Trans-Blot 
Turbo™ transfer system (BioRad), with the blots incubated thereafter for 30 min at RT in a 
blocking solution of 5% non-fat dry milk in PBS. The membranes were incubated overnight at 
4 °C with primary mouse antibodies anti-SOX-9 (Thermo Scientific) and primary rabbit 
antibodies anti-β-actin (Cell Signaling) which served as the internal control. Afterwards, the 
blots were incubated with a horseradish goat peroxidase-linked secondary antibodies anti-
mouse and anti-rabbit (Bio-Rad) for 30 min. An enhanced chemiluminescence kit (ECL, 
BioRad) was used to visualize the protein bands with ChemiDoc XRS+ (Bio-Rad).  
 
1.16. Statistical analysis 
 Results were expressed as mean ± standard error (SEM) plotted on graphs. Following 
statistical tests were used in the studies of this thesis:  
- One-way ANOVA followed by Tukey’s multiple comparisons test: analysis of cell 
proliferation and analysis of mechanical moduli within two experimental groups; 
- one-way ANOVA, followed by Dunnett’s multiple comparisons test: analysis of in vitro 
degradation within many compositions of collagen scaffolds; 
- two-way ANOVA, followed by Sidak’s multiple comparisons test: analysis of 
mechanical moduli as a function of time; 
- two-way ANOVA, followed by Tukey's multiple comparisons test: analysis of cell 
viability, cell proliferation, gene expression and glycosaminoglycans content within 
more than two experimental groups; 
- unpaired Student’s t-test: percentage of porosity within two experimental groups.  
Statistical analysis was performed by the Graph Pad Prism software (version 6.0), with 
statistical significance set at p ≤ 0.05. 
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Chapter 2 
 
DEVELOPMENT OF 3D POROUS GELATIN 
SCAFFOLDS BY DIFFERENT CROSSLINKING 
APPROACHES: COMPARATIVE ANALYSIS 
 
 
 Introduction 
 Scaffolds with biomimetic properties are admittedly desired in the field of tissue 
engineering (TE) as they provide a template for cell growth, cell differentiation, ECM 
components production and thereby, promote new tissue formation in injured cartilage or bone 
[8]. In order to facilitate the healing process of damaged tissue, such 3D scaffolds should be 
tailored to exhibit suitable porosity, mechanical properties and stability in vivo. In addition to 
the 3D porous architecture, great attention must be paid to the scaffold’s composition [9].  
The major group of materials, which have been widely applied for the generation of such 3D 
scaffolds, are natural polymers. Natural polymers as collagen and its denatured form gelatin 
can be functionally superior to synthetic polymers due the presence of specific receptors as Arg-
Gly-Asp motif (RGD) which facilitate cell attachment and cell migration [10], [11]. The natural 
origin and abundance of collagen, especially type I, in mammals tissues make this protein a 
promising candidate for the production of scaffolds in the field of tissue engineering. 
Nevertheless, processing of native collagen required purification from telopeptides and virus 
inactivation which increase the cost of the procedure [12].  
Hence, the alternative option can be a gelatin, which is chemically similar to collagen, but its 
production is less expensive and the antigenicity is lower compared do collagen. Moreover, 
numbers of studies have demonstrated high biocompatibility and proper biodegradability of 
gelatin in vivo as well as feasibility in modulating the physicochemical properties [9], [13], 
[14]. However, there are some limitations in use of gelatin as a scaffold in TE like fast 
dissolution in aqueous environment, thermal instability and poor mechanical properties [15]. In 
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order to overcome these problems crosslinking treatment has been applied to stabilize 
chemically and mechanically the material.   
 Various crosslinking methods are currently in use for scaffolds fabrication such as physical, 
chemical and natural crosslinking. The example of physical method taken in consideration for 
this scientific research is a dehydrothermal crosslinking (DHT) in which by applying the high 
temperature treatment under the vacuum, the water from the material is removed and the 
intermolecular bonds can be created within the polymeric molecules through esterification or 
amide formation [16], [17].  
Another common crosslinking method is a chemical crosslinking which includes a range of 
chemical reactants, for instance, carbodiimide hydrochloride (EDC), glutaraldehyde or 1,4-
butanediol diglycidyl ether (BDDGE) [18]. The last one is a bi-functional epoxy compound 
able to form crosslinks among molecules by reaction between two amine groups or an amine 
group and carboxyl group of amino acids present in the protein depending form the pH of the 
reaction environment [19].  
Among other crosslinkers capable to interact with gelatin units, genipin is a natural compound 
derived from Gardenia jasminoides fruit which has a great potential to be less cytotoxic than 
chemical crosslinkers [20], [21]. More information about crosslinking treatment can be found 
in the part I of this thesis (Introduction, Chapter 4.2). 
 In this work, 3D gelatin porous scaffold were synthesized and stabilized by three different 
crosslinking treatments: i) DHT, ii) BDDGE and iii) genipin with the aim to develop reinforced 
and biocompatible scaffolds for cartilage tissue engineering. A comparative evaluation was 
performed to determine the effect of the various crosslinking strategies on morphology, fluid 
uptake, degradability, thermal behaviour and mechanical properties of the 3D scaffold. Then, 
preliminary in vitro cytotoxicity test with MG-63 osteosarcoma cell line was performed to 
exclude any cytotoxic effect of the scaffolds. Subsequently, more biological tests were carried 
out using human chondrocytes to assess the cell viability, proliferation and morphology, as well 
as gene and protein expression for chondrogenic markers.  
This study has been already published and done together with Gopal Kumar Shankar [12]. 
 
 Preparation of scaffolds 
 Commercial porcine skin gelatin (Type A, Bloom number: 280) was purchased from 
Italgelatine Spa, Italy. The gelatin was dissolved in milli-Q water at 40 °C to obtain the 5 wt% 
aqueous solution. Then, 3D gelatin constructs were prepared as follows (Fig. 3.1):  
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(i) DHT crosslinked scaffolds, henceforth coded as G-DHT: the gelatin solution was filled onto 
a polystyrene Petri plate and allowed to cool at 4 °C to form a gel. Then the gelatin hydrogel 
was lyophilized by freezing at - 40 °C and drying at 25 °C (5 Pascal, LIO 3000 PLT, Italy) for 
48 h under a constant vacuum of 0.1 mbar to obtain porous 3D matrices. Finally, the scaffolds 
were heated at 160 °C under vacuum (0.001 mbar) for 48 h or 96 h. 
(ii) BDDGE crosslinked scaffolds, henceforth coded as G-BDD: the gelatin solution was added 
with various concentration of BDDGE (Sigma Aldrich, USA); from 1.5 wt% up to 40 wt% at 
pH = 8 and then mixed under stirring for 5 min. Later, the resultant mixture was filled onto a 
polystyrene Petri plate and the crosslinking reaction was carried at 25 ± 2 °C for 48 h. 
(iii) Genipin crosslinked scaffolds, henceforth coded as G-GEN: the gelatin solution was added 
with various concentration of genipin (Wako, Germany); from 0.5 wt% up to 2.5 wt% (pH = 5) 
and then mixed under stirring for 5 min. Later, the resultant mixture was filled onto a 
polystyrene Petri plate and the crosslinking reaction was carried at 25 ± 2 °C for 48 h. 
G-BDD and G-GEN samples after crosslinking were freeze-dried following the above 
described procedure.  
After freeze-drying, all new synthesized scaffolds exhibited sponge-like structure. G-DHT 
samples were yellowish, G-BDD white and G-GEN had dark blue color as presented on Fig. 
3.1.  
 
Fig. 3.1. Schematic illustration of fabrication gelatin 3D scaffolds with three different 
crosslinkers. 
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 Physicochemical characterization 
 In this work a comparative study between the performance of three different crosslinking 
methods on gelatin using DHT, BDDGE and genipin was carried out. The amount of cross-
linkers used in this study is based upon the preliminary screening, previous experience and the 
literature. Biomimetic scaffolds for TE should be biodegradable however, they should exhibit 
resistance to degradation at first weeks after in vivo implantation to let for a new tissue 
formation. Taking under consideration the fact that fast dissolution of gelatin scaffolds in 
aqueous conditions is a main limitation of their use, preliminary stability test in PBS (pH = 7.4) 
at 37 °C up to 14 days was carried out in order to choose the most stable compositions (Table 
3.1.).  
 
 
 
 
 
 
 
 
 
 
 
Table 3.1. Preliminary selection of gelatin scaffolds crosslinked with increasing concentrations 
of BDDGE or Genipin or crosslinked with DHT of two different times of reaction, incubated 
in PBS at 37 °C up to 14 days. Preliminary assessment has been performed by macroscopic 
observation where, ‘+’ means stable sample, ‘+/-’ means that sample is losing its structure and 
‘-’ refers to complete loss of structure and sample dissolution. Three samples of each group 
were analysed.  
 
The G-BDD scaffolds of concentration 1.5 wt% and 5 wt% started to losing the structural 
integrity at day 3 and 7 respectively, and at the end of the test (14 days) these samples were 
completely dissolved based on the macroscopic observation. Among G-GEN scaffolds, samples 
crosslinked with 0.5 wt% and 1.0 wt% of genipin were rejected as they exhibited rapid loss of 
structure in the first days of the test. Only samples of the genipin concentration higher than 1.5 
wt% and in case of BDDGE samples with concentration higher than 10 wt% showed stability 
for 14 days in PBS at 37 °C. Finally, the appropriate crosslinker amount was chosen by taking 
Type of 
crosslinker 
concentrations 
(wt%) 
Macroscopic observation with time 
1d 3d 5d 7d 14d 
BDDGE 
1.5 + +/- +/- - - 
5 + + + +/- - 
10 + + + + + 
20 + + + + + 
40 + + + + + 
Genipin 
0.5 + +/- - - - 
1 + + +/- - - 
1.5 + + + + + 
2 + + + + + 
2.5 + + + + + 
DHT 
Time of crosslinking      
48 h + + + + + 
96 h + + + + + 
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into account a minimum concentration of BDDGE (10 wt%) and genipin (1.5 wt%) needed to 
obtain a 3D scaffold with good physical stability [18], [20]. Higher concentrations than selected 
ones could manifest cytotoxic effects during cell culture thus, those concentration were 
excluded from the further experiments (table 3.1) [20], [22]–[24]. 
Gelatin scaffolds crosslinked with DHT for 48 h or 96 h showed preserved structure for 14 days 
therefore, further evaluation was needed to select the best time of crosslinking. After careful 
consideration, BDDGE (10 wt %) named as G-BDD, genipin (1.5 wt %) named as G-GEN and 
DHT (48 h and 96 h) named as G-DHT ’48 h’ and G-DHT ’96 h’ respectively, were selected 
for physicochemical characterization. 
 
Morphology and porosity 
 Architecture of the scaffold, suitable pore size, interconnected pore network and high 
porosity are crucial parameters for tissue engineering application as they can influence cell 
growth, transport of nutrients and metabolic waste, deposition of ECM and finally neo tissue 
formation [25].  
All gelatin scaffolds had a highly porous microstructure with interconnected pores and 
heterogeneous pore size as seen in Fig. 3.2 (A, B, C, D). Observing the longitudinal cross-
section of the scaffolds, the pore dimensions, morphology and pore interconnectivity were also 
well retained within the scaffold walls Fig. 3.2 (E, F, G, H) and no evidence of anisotropic 
distribution were underlined.  
 
Fig. 3.2. Morphology of gelatin scaffolds: (A, E) G-DHT 48h, (B, F) G-DHT 96h, (C, G) G-
BDD, (D, H) G-GEN; Upper panel represents transversal cross-sections and lower panel 
longitudinal cross-sections. Scale bar 500 µm. 
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 The average pore size of the scaffolds was measured from the swollen samples, cut into 
thin cross-sections as demonstrates the image in Table 3.2. The range of average pore size, was 
between 346 ± 10 µm for G-DHT ‘96 h’, 354 ± 17 µm for G-BDD scaffold, 368 ± 10 µm for 
G- GEN and 390 ± 14 µm for G-DHT ‘48 h’ (Table 3.2).  
 Adequate porous morphology is considered to be an indispensable element of biomaterials, 
as this structural feature greatly contributes to extensive cell colonization [1]. Therefore, total 
porosity (%) measured by gravimetric method and macropores porosity (%) measured by water 
squeezing method were analysed showing no significant differences among the samples i.e.; 
about 93-94% of total porosity for all scaffolds, 65-66% of macropore porosity for both G-DHT 
and G-BDD and 51.2 ± 4.3% for G-GEN (Table 3.2). The results obtained from these two 
methods of porosity measurements cannot be compared due to differences in the principle and 
in the sensitivity. Summarizing, all scaffolds showed high total porosity and sufficient 
macropore porosity which is normally lower than total porosity [2], [26]. 
Although, there were slight differences in the homogeneity or average pore size, all types of 
scaffolds showed satisfactory porosity and pore size suitable for cell penetration and 
colonization. 
  
 
Table 3.2. Morphological characteristics of gelatin scaffolds. Average pore size (µm) 
determined by measurement of 50 pores in the scaffolds cross-sections after 24h of swelling in 
PBS (n = 50, data are mean ± SEM). On the right: representative image of 50 µm cross-section 
of G-DHT 48h sample, embedded in OCT and cut on the cryostat after immersion. Percentage 
of porosity measured by gravimetric method (total porosity) and water squeezing method 
(macropore porosity) (n = 3 data are mean ± SEM).  
 
Fluid Uptake  
 Fluid binding capacity is an important feature of scaffolds for tissue regeneration, which is 
function of their surface chemistry and roughness. This knowledge is important from the 
perspective of materials interacting with physiological fluid and cells because this greatly 
determines the structural properties and cell-material interaction under in vivo conditions [27]. 
Fig. 3.3 represents the time-dependent swelling behaviour of the gelatin scaffolds showing the 
 
Scaffold type 
Average 
pore size 
(µm)   
Porosity (%) 
Gravimetric 
method 
Water 
squeezing 
method 
G-DHT 48h 390 ± 14 94.3 ± 0.6 66.0 ± 3.8 
G-DHT 96h 346 ± 10 93.2 ± 0.2 65.0 ± 4.9 
G-BDD 354 ± 17 94.0 ± 0.1 66.6 ± 4.8 
G-GEN 368 ± 10 94.7 ± 0.3 51.2 ± 4.3 
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highest fluid uptake value for G-GEN scaffold, i.e. 644 ± 16% and 1111 ± 1% at 1 and 72 h, 
respectively. The fluid uptake index at 72 h for other scaffolds was 609 ± 6% for G-DHT ‘48 
h’, 458 ± 15% for G-DHT ’96 h’ and 658 ± 26% for G-BDD.  
 
Fig. 3.3. Fluid uptake as a function of time of G-DHT (crosslinked for 48h and 96h), G-BDD 
and G-GEN scaffolds at 37 °C. 
 
Although fluid uptake index for G-DHT ‘48 h’ was the lowest, this scaffold could absorb PBS 
more rapidly than others, which can be explained by 3-fold increase in fluid-retention ability of 
the material between 1 h and 72 h of incubation. Whereas, G-DHT ’96 h’, G-BDD and G-GEN 
showed only 1.3, 1.8 and 1.7-fold increase respectively (Fig. 3.3). The results of fluid uptake 
showed that the scaffolds were hydrophilic in nature with capacity to hold equitable water 
molecules. The ability of the material to interact and hold the water molecule within its network 
is greater dependent upon the micro-architecture of the scaffolds [28]. Moreover, our results 
demonstrated that the presence of suitable porosity in all four scaffolds (Table.3.2) might 
eventually increase the water-retention resulting in good swelling property with maintaining 
physical stability.  
 
Extent of crosslinking  
 The extent of crosslinking of gelatin scaffolds was calculated from the moles of free amino 
groups per gram of gelatin. The results as illustrated in Fig. 3.4 A showed that BDDGE was 
sufficient to crosslink 73% of the free amino groups of gelatin whereas, the genipin was able to 
crosslink only 30%. Among DHT crosslinked scaffolds, the G-DHT ’96 h’ crosslinked in 41%, 
exhibited higher crosslinking degree than G-DHT ’48 h’ sample (31%), which can be correlated 
to the longer time of crosslinking in the first group (Fig. 3.4 A).   
These results manifested that the concentration of coupling agents, time of crosslinking reaction 
as well as type of crosslinking can be an essential determinant of crosslinking degree. Probably, 
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the G-BDD scaffolds are crosslinked in a higher extent than G-GEN due to higher amount of 
crosslinker used in the reaction: 10 wt% of BDDGE and 1.5 wt% of genipin. 
Fig. 3.4. (A) Percentage of crosslinking degree expressed as free amine group content per 
scaffold (B) Degradation assay expressed as change in weight (%) of gelatin scaffolds during 
21 day test in PBS at 37 °C. For both tests three samples per condition of each group were 
measured (n=3 data are mean ± SEM). 
 
 Furthermore, diverse crosslinking strategies can led to different extents of crosslinking. 
High crosslinking degree of G-BDD may be related to the fact that BDDGE contrary to genipin, 
can react with several functional side groups within the gelatin backbone, which readily 
undergoes chemical modification. In G-DHT group, the high temperature treatment tends to 
completely remove the bound water from the material resulting in less surface energy available 
for crosslinking [16]. Whereas in G-GEN group, increasing the genipin concentration more 
amino groups would be crosslinked that eventually would led to higher degree of crosslinking. 
However, the minimum genipin concentration was used to avoid any cytotoxic response, 
moreover the crosslinking index observed for G-DHT and G-GEN according to the literature 
was highly sufficient and suitable for tissue engineering application [29].  
 
Evaluation of degradation rate 
 Degradation test was carried out to investigate the stability of the scaffolds and their mass 
loss with time under physiological conditions. From the macroscopic observation, there was no 
loss of shape or weakening of structural architecture of the scaffolds when compared to the non-
crosslinked gelatin samples which rapidly dissolved within 1 h of incubation in PBS (pH = 7.4) 
at 37 °C. The highest weight loss was observed for G-GEN, which had a dissolution level of 37 
± 1% at day 21 (Fig. 3.4 B). Among two G-DHT groups there was a slight difference in the 
weight loss, beneficial towards G-DHT ’96 h’ at the initial time points whereas, at day 21 the 
dissolution level of G-DHT ’96 h’ was higher than G-DHT ’48 h’, 21 ± 1% and 19 ± 2% 
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respectively. The overall mass loss of G-BDD was very low, only 2.0 ± 0.5% at day 21 which 
indicates that this scaffold was the most stable under physiological conditions (Fig. 3.4 B). 
Nevertheless, in the field of TE biodegradability of the materials is extremely important and 
too slow degradation can disturb a new tissue formation. Additionally, the low dissolution rate 
of the G-BDD can also be associated with high heterogeneity of the material or with the 
crosslinking degree data, which showed the highest crosslinking index for G-BDD (73.0 ± 
0.44%) which eventually endowed the lower dissolution rate (Fig. 3.4 A, B). Whereby, it is 
evident that the effective crosslinking provided the formation of strong covalent bridges through 
hydroxyl group bonding, which is less accessible to dissolution.  
 
 From the presented so far scaffold characterization tests, there were no significant 
differences in terms of swelling properties, microstructure, porosity and degradation between 
G-DHT ’48 h’ and G-DHT ’96 h’. Then taking into account, the time consumed for scaffolds 
fabrication and economical aspects the G-DHT crosslinked for 48 h is more favourable and 
therefore further analyses are continued only with this scaffold coded from now as G-DHT.  
 
Fourier Transform Infrared Spectroscopy (FTIR) 
 The FTIR spectra of the obtained scaffolds clearly show three characteristic peaks 
belonging to gelatin (Fig. 3.5) corresponding to Amide I at 1690 cm-1 due to C-O stretching, 
Amide II at 1560 cm-1 due to N-H deformation and Amide III at 1250 cm-1 due to C-N stretching 
vibrations [30]. 
 
Fig. 3.5. FTIR spectra of G-DHT, G-BDD, G-GEN scaffolds and non-crosslinked gelatin. 
 
There were no distinguishable vibrational changes in the spectral peaks of G-DHT and G-BDD 
scaffolds and their spectra appeared similar to the parent molecule. The G-GEN showed a 
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spectral peak at 1650 cm-1 which corresponds to the C=N stretching of amine groups in the 
gelatin molecule to form a secondary amide through carboxymethyl group interaction of 
genipin. Another vibrational change at 1100 cm-1 indicates the stretching vibration of 
dihydropyrane ring (heterocyclic ring opening) of genipin thus ensuring effective crosslinking 
of gelatin [31]. In conclusion, the FTIR results confirm that the presence of crosslinkers did 
modify the chemical properties of the scaffolds to an extent without causing any detrimental 
effects on the biocompatibility of the scaffolds. 
 
Thermal Characteristics  
  The change in weight in relation to temperature was evaluated from the thermal 
decomposition pattern of the material. The weight loss of all scaffolds was consistent from 100 
to 600 °C, after which there was a rapid degradation as seen in the pyrolytic pattern (Fig. 3.6). 
The initial weight loss was observed between 50-90 °C, mainly due to loss of water molecules. 
The second weight loss between 250-300 °C is due to destabilization of macromolecule, leading 
to thermal degradation. All three scaffolds (G-DHT, G-BDD and G-GEN) exhibited a similar 
pyrolytic pattern with very slight differences in the degradation profile.  From the TGA peaks, 
it can be observed that the presence of crosslinkers did attribute to the increase in thermal 
durability of the material. The various crosslinking methods have led to increase in length of 
gelatin molecule thereby ensuring better thermal stability [32]. 
 
Fig. 3.6. TGA curve pattern of G-DHT, G-BDD, G-GEN scaffolds and non-crosslinked gelatin. 
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 Mechanical properties 
Static mechanical analysis  
 Cartilage tissue is constantly subjected to the compressive forces thereby, scaffolds used 
for cartilage tissue engineering have to be well characterized concerning their mechanical 
properties. It is also important to underline that materials need to be hydrated prior to testing in 
order to mimic realistic conditions [33], [34].  
 Uniaxial compression test as well as dynamic compression test under oscillatory loading 
were performed to understand mechanical properties of gelatin scaffolds. The distinct material 
response can be observed in the stress-strain curves pertaining to different crosslinkers as seen 
in Fig. 3.7 A. G-DHT exhibited the strongest material with mostly elastic region (linear portion 
of the stress-strain curve) with no failure until the highest force (5 N) was applied. G-BDD also 
showed elastic behaviour with no visible collapse plateau in the present strain range. G-GEN 
seems to be the softest materials, which at the maximum force 5 N had already 78% of strain 
(deformation) while G-DHT and G-BDD reached 62% and 68% of strain respectively. The 
compressive modulus was the highest for G-DHT (54.4 ± 3.8 kPa) followed by G-BDD (46.0 
± 2.8 kPa) and G-GEN (16.2 ± 0.3 kPa) (Fig. 3.7 B). G-GEN showed significant decrease in 
compressive modulus respect to G-DHT and G-BDD (p ≤ 0.0001).  
This analysis clearly demonstrated that DHT crosslinking provides sufficient and higher 
resistance of gelatin scaffold under compression compared to other constructs (Fig. 3.7). 
Additionally, the compressive moduli of our scaffolds were greatly higher than those found in 
the literature regarding cartilage tissue application [2], [35]. 
 
Fig. 3.7. Mechanical properties of gelatin scaffolds. (A) Representative stress-strain curves and 
(B) Compressive moduli of  G-DHT, G-BDD and G-GEN scaffolds hydrated in PBS at 37 °C 
for 24 h; tested at force 0,5 N/min; Data are mean ± SEM from 5 samples each type of scaffold. 
Statistically significant differences between G-DHT and G-GEN (****p ≤ 0.0001) and between 
G-BDD and G-GEN (****p ≤ 0.0001). 
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Dynamic mechanical analysis 
 Viscoelastic properties of gelatin scaffolds were evaluated by dynamical mechanical 
analysis (DMA). DMA test carried out at varying frequencies showed differences in stiffness 
and viscoelastic behaviour among the compositions (Fig. 3.8). The storage modulus (E’) of all 
the scaffolds increased with increasing frequency (Fig. 3.8 A). G-DHT showed the highest 
storage modulus that increased from 41.6 ± 3.1 kPa at the frequency 0.1 Hz to 58.8 ± 6.0 kPa 
at 10 Hz. For G-BDD and G-GEN storage moduli increased at lower rates, giving rise from 
36.4 ± 1.2 to 44.4 ± 1.2 kPa for G-BDD and from 17.9 ± 0.8 to 24.0 ± 1.4 kPa in case of G-
GEN. These data underlined that G-DHT promoted the stiffness of the scaffolds in a higher 
extent respect to two other groups. In literature it has been reported that scaffold’s stiffness and 
compressive modulus decrease with increasing pore size [36]. In our study the highest modulus 
value was observed for G-DHT sample which apparently had the biggest pore size (Table 3.2) 
however, this effect can be counterbalanced by the hydrostatic interaction of the water 
molecules within the large pores which prevents material deformation and eventually results in  
higher E’[37].  
 Another important parameter of viscoelasticity is the loss factor (tan δ), which is the ratio 
of the amount of energy dissipated, representing the viscous portion to energy stored, 
representing the elastic portion [28], [37]. The loss factor (tan δ) of G-DHT and G-BDD 
increased up to certain frequency (3.4 Hz and 4.5 Hz respectively) and after started to drop until 
10 Hz, which indicates that these scaffolds at particular point became more elastic than viscous 
(Fig. 3.8 B). For G-GEN, tan δ is decreasing from the beginning of test, showing only its elastic 
response upon increasing frequencies. After frequency of 2.3 Hz, negative values of tan δ were 
observed and they were not included on the graph. At low frequencies, the loss factor of G-
DHT and G-BDD increased, demonstrating their higher damping capabilities than G-GEN. 
Moreover, G-DHT is able to store more energy maintaining the viscous response at higher 
frequency when compared to G-BDD. Inversely, the G-GEN scaffold represented mostly elastic 
behaviour without suitable viscosity and stiffness which is necessary in amortization of 
compressive loading present in articular cartilage [37], [38]. 
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Fig. 3.8. Viscoelastic properties of the gelatin scaffolds. (A) Storage modulus (E’) and (B) loss 
factor (tan δ) of G-DHT, G-BDD and G-GEN scaffolds hydrated in PBS at 37 °C for 24 h; 
tested at varying frequencies; Data are mean ± SEM from 5 samples each type of scaffold. 
 
 Biological evaluation  
2.5.1. Preliminary cytotoxicity assessment 
 Preliminary in vitro studies were performed to investigate safety of the gelatin scaffolds in 
terms of their potential cytotoxicity. For this purpose, cell viability and cell proliferation assay 
were carried out using Human Osteosarcoma cell line MG-63, which is a commonly used cell 
line for the cytotoxicity tests [39]–[41]. Moreover, the impact of scaffold properties on cell 
morphology was also examined.  
 
Cell viability  
 Cell viability of the cells seeded on the G-DHT and G-BDD constructs was visualized by 
Live&/Dead assay (Fig. 3.9). This test could not be performed on G-GEN scaffold due to the 
auto-fluorescence of the sample giving a brighter background in TRITC filter (578 nm) which 
leads to difficulties in visualizing the dead cells. Instead, the nuclear morphology integrity as 
index of cell viability was evaluated using nuclear fluorescent dye (DAPI staining, Fig. 
3.10) [42].  
Both G-BDD and G-DHT cell-seeded scaffolds demonstrated high cell viability with hardly 
detectable dead cells at each time point. The increase of cell density over the experimental time 
can be observed for both tested groups (Fig. 3.9 A, B).  
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Fig. 3.9. Cell viability analysed by the live/dead assay (Calcein stains live cells in green, 
Ethidium homodimer-1 stains dead cells in red). Panel A presents G-DHT scaffold and panel 
B, G-BDD scaffold at time points: 1 day, 2 days, 3 days and 7 days. Scale bars: 200 µm.  
 DAPI staining showed proper round morphology of cell nuclei in all three scaffolds, 
visualized in blue. Also here, the cell density increased with time as amount of cell nuclei is 
higher after 7 days compared to 3rd day of culture, emphasizing good cell colonization of the 
material (Fig. 3.10). Additionally, cells growing on G-GEN are more uniformly distributed than 
other constructs whereas, in G-BDD, cells are distributed more on the edges of the pores (Fig. 
3.10, Fig. 3.9 B). The results from Live&/Dead assay and DAPI staining showed good 
cytocompatibility of all scaffolds demonstrating that not all the three crosslinkers are cytotoxic 
in the presented crosslinking conditions. 
 
Fig. 3.10. Index of cell viability of G-DHT, G-BDD and G-GEN scaffolds analysed by DAPI 
staining at day 3 and day 7. Images represent upper surface of the scaffolds and cell nuclei are 
stained in blue. Scale bars: 200 µm. 
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Cell proliferation 
 Cell proliferation was evaluated by the MTT assay showing the increase in cell growth over 
time for the G-DHT and G-BDD scaffolds (Fig. 3.11). The difficulties with G-GEN scaffolds 
appeared also in this test and cell proliferation could not be obtained for this composition. The 
explanation of this event can be a very high absorbance of genipin that disturbs the reading of 
optical density (OD) during MTT assay. The standard procedure in our laboratory is to incubate 
acellular blank scaffolds in the same conditions as cell-seeded constructs and in case of MTT 
test, the real OD of the sample is calculated by subtracting the absorbance of a blank scaffold 
from the cell-seeded one. Hence, the final absorbance is an absorbance only of the cells 
however, for G-GEN samples blank scaffolds had higher OD than cell-seeded constructs which 
can be influenced by genipin properties interfering with colorimetric reaction of MTT [24].  
 The results from MTT assay of G-DHT and G-BDD scaffolds showed that cells proliferated 
in a slightly higher extent in the G-DHT group up to 3 days and after 7 days, higher proliferation 
exhibited G-BDD which was statistically significant compared to G-DHT (**p ≤ 0.01; Fig. 
3.11). 
 
Fig. 3.11. Analysis of cell proliferation by the MTT assay after 24 h, 48 h, 72 h and 7 days of 
cell seeding (MG-63 cell line). Data are mean ± SEM; **p ≤ 0.01. 
 
Lack of results from the cell proliferation for G-GEN is a limitation of this preliminary study. 
Nevertheless, DAPI images of G-GEN showed good cell viability and increase of cell density 
after 7 days, excluding any cytotoxic effects of 1.5 wt% genipin used, and it was the aim of the 
preliminary cytotoxicity assessment. For further in vitro tests, special pre-wash of the scaffolds 
is recommended to well washout the unbound genipin that can conflicts with OD reading. 
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Cell morphology 
 Preliminary analysis of cell morphology was assessed by actin-phalloidin staining and the 
representative images of G-GEN scaffold in low and high magnification are presented in Fig. 
3.12. The analysis revealed good results in term of cell adhesion and morphology verified after 
7 days of cell seeding and no differences were observed for all the scaffolds tested.  
 
Fig. 3.12. Representative images of cell seeded G-GEN scaffolds after phalloidin staining at 
day 3 (A) and day 7 (B). Actin cytoskeleton stained in green and cell nucleus in blue.  
(A) magnification 10x, scale bar: 200 µm; (B) magnification 40x, scale bar: 50 µm. 
 
Cell–surface interaction and cell adhesion are complex processes involving the reorganization 
of cytoskeleton proteins like actin, and it has an impact on overall material’s biocompatibility 
[43], [44]. In the presented images, cells attached and spread on the scaffold’s surface with 
visible in green actin filaments and normal-shaped cell nuclei visualized in blue. Cells 
possessed fibroblast-like morphology typical for human MG-63 osteoblast-like cells and 
created cell protrusions to enable for cell-cell contact.  
 
2.5.2. In vitro tests with human chondrocytes 
 Biological evaluation with gelatin scaffolds using human chondrocytes cell line (CHON-
002) has been continued. Cell-scaffold interaction was deeply investigated by assessing 
viability, proliferation and morphology of the cells, as well as glycosaminoglycans content, and 
gene/protein expression.  
 
Cell viability 
 The cell viability of the chondrocytes on the porous gelatin scaffolds was visualized by 
live/dead assay. The fluorescence of the dead cells were not visible in the G-GEN due to the 
difficulties described earlier (paragraph 2.5.1).  Therefore, the cell viability and colonization on 
the G-GEN scaffolds were examined through DAPI staining.  
As represented in Fig. 3.13, the G-BDD and G-DHT scaffolds demonstrated high cell viability 
representing good cytocompatibility at each time point. With the increase in culture time there 
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was increase in cell density especially on day 7 and 14 and the cells appeared to be equally 
distributed in both the scaffolds surface.  
 
 
Fig. 3.13. Cell viability analysed by the live/dead assay (Calcein stains live cells in green, 
Ethidium homodimer-1 stains dead cells in red). Panel A. presents G-DHT scaffold and panel 
B. G-BDD scaffold at time points: 1 day, 3 days, 7 days and 14 days. Scale bars: 200 µm. 
 
 
 
Fig. 3.14. Cell colonization of G-DHT (A), G-BDD (B) and G-GEN (C) scaffolds analysed by 
DAPI staining at day 1, 7 and 14. Cell nucleus stained in blue. Scale bars: 200 µm. 
Moreover, DAPI staining of the G-GEN showed proper round cell nuclei morphology 
visualized in dark blue and along the time, there was increase in cell colonization of the material 
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(Fig. 3.14 A-C). Both the live/dead and DAPI images shows the gradual increase in cellularity 
with respect to increase in culture time indicating the absence of cytotoxicity of the studied 
material. There was no difference in terms of cell viability amongst the scaffolds and the 
presence of crosslinkers did not impede the chondrocytes expansion and scaffold colonization. 
 
 Cell proliferation 
Cell proliferation was evaluated by the MTT assay showing the increase in cell growth 
with time for all the scaffolds (Fig. 3.15). Comparing to the previous preliminary test on MG-
63 osteoblast-like cells, this time all scaffolds were washed properly in cell culture medium for 
24 h prior to starting the 3D cell culture and the absorbance of acellular scaffolds, especially G-
GEN, was reduced.  
The highest cell proliferation was observed for G-DHT which was statistically significant when 
compared to G-GEN at day 7 and 14 (p ≤ 0.05; p ≤ 0.0001) and to G-BDD at day 7 and 14 (p 
≤ 0.05; p ≤ 0.01). Comparing the G-BDD and G-GEN, the higher cell proliferation rate was 
observed for G-BDD with statistically significant difference at day 7 and 14 (p ≤ 0.05; p ≤ 
0.0001). The cell metabolic activity was observed to be in the order: G-DHT> G-BDD> G-
GEN as the culture time is prolonged. 
 
Fig. 3.15. Analysis of chondrocytes proliferation by the MTT assay after 1, 3, 7 and 14 days of 
cell seeding (n = 3). Cells seeded on G-DHT and G-BDD scaffolds proliferate in a higher extent 
compared to cells growing in G-GEN scaffold. *p ≤ 0.05; **p ≤ 0.01; ****p ≤ 0.0001. 
 The DAPI staining results can be correlated with the MTT assay. The results elucidated a 
significant increase in number of viable cells in all the scaffold groups as the culture time is 
prolonged. Nevertheless, when compared to other scaffolds, G-GEN scaffold exhibited slower 
growth rate and recover in the later stage of culture time. The possible explanation that can 
contribute to the slower growth rate can be the reaction of genipin with the primary amine 
groups of arginine residues of gelatin leading to reduction of adhesion promoting RGD-like 
sequence [16], [45]. Moreover, previously several authors have reported the toxicity of genipin 
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and they have speculated to be cell and dose dependent [24], [46]. However, the observations 
of the culture studies also provide the evidence that the crosslinking mechanism assists in 
providing a more suitable microenvironment for the overall cellular activity, which in turn 
benefitted their proliferation as well.   
 
Cell morphology and cell attachment  
 Spherical shape of primary chondrocytes is a typical morphology present in native 
cartilage. The human chondrocytes cell line CHON-002 (ATCC (clone number 2847™) used 
in this study derived from the long bone of an 18-week-old female foetus and was infected by 
the defective retrovirus containing human telomerase reverse transcriptase gene under G418 
selection [47]. The primary cells after immortalization, as in case of CHON-002 cells develop 
fibroblast-like morphology and can have lacks of some gene expression as has been already 
reported [47]–[50]. The morphology of our chondrocytes (CHON-002) was firstly observed in 
2D and presented in Fig. 3.17 showing indeed spindle-shaped cells with filopodia extensions.  
 
Fig. 3.16. Representative images of human chondrocytes (cell line; CHON-002, ATCC) 
morphology adapted from: www.lgcstandards-atcc.org (images on the left) and cells culture in 
2D in our laboratory on passage 2 (the image on the right; scale bar: 200 µm). The image taken 
in bright field by optical microscope (Nikon).  
 
 The microenvironment quality and the compatibility of scaffolds for cellular infiltration 
was evaluated using SEM. After 7 days of cell culture, the human chondrocytes were able to 
adhere, grow and penetrate into the porous material as seen in Fig. 3.17 (A-F). The porous 
nature of the scaffold enabled easy cell attachment and infiltration. There was no difference in 
the cell morphology on different scaffolds, all the scaffolds accommodated the chondrocytes to 
expand and grow with branched spindle shaped morphology. The SEM analysis revealed that 
chondrocytes were able to attach and spread over all the scaffolds, forming multiple protrusions 
without any polarization or aggregation (Fig. 3.17). The presence of interconnecting porous 
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texture characterized by the presence of heterogeneous macro and micro pores could facilitate 
cell adhesion and penetration [1].  
 
Fig. 3.17. SEM images showing cell-scaffold interactions 7 days after seeding. Cell layers 
(marked with yellow arrows) in direct contact with the biomaterials shows high 
cytocompatibility of the scaffold itself. (A, D): G-DHT, (B, E): G-BDD and (C, F): G-GEN. 
Scale bars: (A, B, C) 200 µm; (D, E, F) 50 µm. 
 
Glycosaminoglycans content 
 The amount of GAGs produced by the cells in correspondence to the culture time was 
increased between day 7 and 14 for all the scaffolds without any significant differences (Fig. 
3.18). High level of glycosaminoglycans produced by the cells proved the rich deposition of 
cartilage extra cellular matrix components by the chondrocytes.  
 
Fig. 3.18. GAG deposition by chondrocytes on G-DHT, G-BDD and G-GEN scaffolds after 7 
and 14 days of culture. No statistically significant differences among the scaffolds were noticed. 
 
Proteoglycans are considered to be the major ECM component of cartilage synthesized by 
chondrocytes. Since the proteoglycans are composed of 95% GAGs and 5% protein, it is always 
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essential to measure the GAG content in order to understand the metabolic activity of the cells 
[51]. Accordingly, the cells in all the scaffolds were able to secrete more ECM as the culture 
time prolonged. These results can be coordinated with the scaffold morphology and pore size 
distribution. The results of GAG quantification suggests that the average pore size of 350 µm 
helps the chondrocytes to infiltrate and secrete their ECM components through efficient 
transport of the nutrients or metabolites. Moreover, it has been reported that chondrocytes 
showed preferential proliferation and ECM production for scaffolds with pore sizes between 
250 and 500 µm [22]. Additionally, the good hydration properties of the scaffolds also helped 
in providing the required microenvironment for cell migration and proliferation. Furthermore, 
the yield of GAG content was considerable and comparable to results reported in the literature 
[52]. 
 
Analysis of gene expression  
 A suitable scaffold for cartilage TE should not only facilitate cell growth, but it should also 
support chondrogenic phenotype in order to allow functional cartilage matrix to be formed [53]. 
Following this purpose, the preliminary evaluation of chondrogenic gene expression was 
performed by qPCR. The chondrogenic markers included transcription factor SOX-9 and the 
main member of proteoglycans, Aggrecan (ACAN) [38]. At the designed time points RNA 
isolated from cells, seeded on the gelatin scaffolds underwent reverse-transcription qPCR 
reaction and the relative gene expression was analysed respect to the housekeeping gene 
GAPDH (Fig. 3.19) [54].  
The mRNA level of SOX-9 increased between day 7 and day 14 of cell culture for all three 
gelatin scaffolds (Fig. 3.19 A). Then at day 21 there was a slight decrease in the relative gene 
expression which can be explained by the fact that SOX-9 plays a key role in the early stage of 
cartilage formation therefore, at the later time of culture its level can be lower [55]. Even if no 
significant differences were reported at day 14 and day 21, the highest mRNA level of SOX-9 
referred to level of GAPDH was observed for G-DHT (Fig. 3.19 A). This transcription factor 
is highly essential in maintaining the chondrocytes phenotype and also guides the chondrocytes 
in expressing hyaline cartilage specific genes [56].  
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Fig. 3.19. Gene expression analysis of SOX-9 and Aggrecan (ACAN) gene. Relative 
quantification of gene expression after 7, 14 and 21 days of chondrocytes culture on the gelatin 
scaffolds. Data represent fold changes of target genes relative to the housekeeping gene 
GAPDH. No statistically significant differences noticed in expression of SOX-9; statistically 
significant increase of mRNA level of ACAN observed for G-DHT and G-GEN at day 21. 
(****p ≤ 0.0001). 
The gene expression of aggrecan was also evaluated showing low mRNA level in the initial 
time points for all gelatin scaffolds and then at day 21 the high increase in the ACAN expression 
was observed with statistically significant difference for G-DHT and G-GEN compared to G-
BDD (****p ≤ 0.0001; Fig. 3.19 B). Aggrecan plays an important role in structure and function 
of cartilage and its expression starts at the later time of the cell culture [55], [57]. Surprisingly, 
very low expression of ACAN gene at day 14 cannot be correlated to the high quantity of GAGs 
at the same day of culture. These diverse results can be related to post-transcriptional 
modifications of mRNA and moreover, further experiments of gene expression analysis are 
highly demanded. Nonetheless, the induction of SOX-9 and ACAN gene observed in cell-
seeded gelatin scaffolds could be attributed to the structural suitability of the constructs 
promoted by the DHT, genipin and BDDGE crosslinkers.  
 
Analysis of protein (SOX-9) expression  
 In order to detect SOX-9 protein in the chondrocytes growing on the gelatin scaffolds after 
7 and 14 days of culture western blot analysis was performed using anti-SOX-9 and anti-β-actin 
antibody, which was used as an endogenous control (Fig.3.20). Acellular scaffolds were used 
as control and their protein concentration was subtracted from the concentration of cellular 
constructs before loading on the gel in order to eliminate the aspecific signal from the results. 
Additionally, lysates from the blank scaffolds were also load on the electrophoresis gel and 
underwent the same immune-detection. 
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Fig. 3.20. Western blot analysis of SOX-9. The image represents protein bands from day 7 and 
14 of (A) cell-seeded scaffolds and (B) scaffolds alone. β-actin was used as a control.  
 
As can be seen in Fig. 3.20 A, SOX-9 protein is present in all three gelatin constructs. 
Accordingly, with the gene expression results, at day 14 the level of SOX-9 protein seems to 
be higher respect to day 7 (Fig. 3.20 A). In the blot from the blank scaffolds (negative control), 
the protein band of β-actin due to aspecific signal was observed therefore, quantification of 
SOX-9 expression which normally should be normalized to the expression of β-actin, was not 
performed (Fig. 3.20 B). Detection of β-actin in acellular scaffolds can be related to natural 
origin of our material, insufficiently purified collagen/gelatin or unspecific binding of 
antibodies. Nevertheless, bands of SOX-9 were noticed only for cell-seeded constructs, which 
confirms expression of this important for formation and functionalization of cartilage protein, 
by chondrocytes.  
 
 Conclusions  
 The present study reported a comparative analysis of various crosslinking agents used to 
reinforced and modified gelatin macromolecule for tissue engineering application. Evaluating 
the influence of thermal (DHT), chemical (BDDGE) and natural (Genipin) coupling agents on 
the gelatin reinforcement, we found that the thermal crosslinking process was more appropriate 
to obtain a 3D scaffold with physicochemical, mechanical and biological features suitable for 
tissue engineering. We demonstrated that thermal dehydration of the gelatin improves the 
overall characteristics without affecting the biological properties of the G-DHT scaffold. 
Moreover, the absence of any chemical residues within the protein network would absolutely 
avoid the antigenicity in physiological conditions. Similarly, the G-BDD a chemically 
crosslinked scaffold showed good mechanical behaviour with acceptable chemical 
composition, topography, hydrophilicity and satisfying biological properties. Whereas, the G-
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GEN scaffolds also showed good morphological features however lower cytocompatibility was 
observed when compared to other two scaffolds but there was slow recovery in the 
compatibility in the later days of culture due to the cell and dose dependent effect of genipin. 
Additionally, G-GEN represented lower resistance to compression and lower viscosity respect 
to other scaffolds.  
 Taken collectively, our results we can conclude that, the adopted procedures to develop and 
stabilized a gelatin based 3D porous scaffolds endowed with high, interconnected porosity 
suitable for cell colonization and tissue regeneration, is worthwhile. The evaluations performed 
on diverse typologies of samples obtained by the three selected crosslinking mechanisms 
suggested that the dehydrothermal treatment is the most effective to obtain promising scaffolds 
for cartilage tissue engineering. 
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Chapter 3 
 
DESIGN AND FABRICATION OF 3D COLLAGEN 
SCAFFOLDS REINFORCED BY GLYCATION 
 
 
 Introduction 
 Abnormalities in articular cartilage can produce pain and deteriorate quality of life, which 
finally can lead to development of osteoarthritis (OA). To prevent progression of OA, cartilage 
defects have to be treated satisfactory and biomaterials play here an important role to support 
regeneration of the damage tissue. Although, incorporation of many biomaterials into field of 
cartilage regeneration, appropriate treatment is still hard to achieve [34], [58]. The idea of 
fabricating innovative scaffolds for tissue engineering is to synthesize materials that can 
conclusively mimic the native tissue. Following this purpose 3D porous material with suitable 
microstructure, optimal biodegradation rate and good mechanical properties, especially in 
cartilage tissue engineering, is necessary to attract the autologous cells and support tissue 
regeneration [34], [59]. Collagen as it has been already mentioned is one of the natural 
polymers, widely used in cartilage repair approaches, as can support cell adhesion and cell 
signalling. Although collagen has been found to be biocompatible and possess low antigenicity, 
its mechanical properties and fast dissolution in physiological conditions need to be tailored 
prior to any in vivo applications [59], [60]. To improve collagen stability and mechanical 
strength several components, mostly chemical, have been employed to crosslink collagen-based 
materials including carbodiimide, glutaraldehyde, 1,4-butanediol diglycidyl ether and more 
[12], [18], [61], [62]. Many studies confirmed the beneficial role of these crosslinkers; however, 
their cytotoxicity in certain concentration can be a limitation of their use [60].  
 In this study we proposed a non-enzymatic crosslinking (glycation) by reducing sugar 
ribose as an alternative crosslinking strategy for cartilage TE. The fibrous collagen undergoes 
the non-enzymatic crosslinking basically, by creating intermolecular bridges between amino 
groups of two adjacent collagen molecule [63]. Before that, Maillard reaction and Amadori 
rearrangements occur and advanced glycation end products (AGEs) can be formed as was 
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described in details in part I of this thesis, section 4.2.4 [64]–[66]. AGEs in a high concentration 
cause stiffening tissues and accelerating protein oxidation as it has been demonstrated 
particularly in diabetics [67], [68]. Definitely, glycation can influence collagen on many ways, 
in which improving its strength and resistance to degradation is one of our interests. In our 
studies we chose ribose as a reducing sugar rather than glucose due to higher crosslinking 
efficiency of ribose compared to other sugars [66], [69], [70]. A few studies have already 
presented the positive effect of ribose crosslinking on the viability of human lung fibroblasts in 
vitro and its long-lasting efficiency as a dermal filler has been confirmed in a rabbit model [71], 
[72]. To our knowledge only one study showed pre- and post-glycation of collagen gel for 
cartilage tissue engineering approach focusing on measurement of the GAG release and 
viscoelastic properties [65]. Nonetheless, this study corresponds to non-freeze dried collagen 
gels and we did not find any other reports that may include broad analysis of non-enzymatic 
pre- and post-crosslinking on 3D porous scaffolds. 
 Therefore, ribose as a natural, easily accessible and low-cost crosslinker has been chosen 
to stabilize collagen fibers in order to produce 3D porous scaffolds that can be potentially used 
for cartilage repair. Two different crosslinking strategies have been applied as is presented on 
Fig. 4.1: a) pre-crosslinking (PRE) where, crosslinking reaction occurred before freeze-drying 
by mixing collagen fibers with the ribose solution and b) post-crosslinking (POST) where, the 
reaction was carried out after freeze-drying by immersion of 3D collagen scaffolds in the ribose 
solution. The ribose-collagen compositions were prepared in different weight ratios and various 
crosslinking reaction times in order to achieve optimal crosslinking conditions.  
The aims of this work were: 1) to verify the effectiveness of ribose glycation as an alternative 
model in order to create stable 3D porous collagen scaffolds for cartilage tissue engineering; 2) 
to comparatively investigate two different non-enzymatic crosslinking methods, PRE- and 
POST-crosslinking, in terms of biodegradability, fluid absorption, microstructure, porosity, 
chemical bonding characteristics and mechanical behaviour. Additionally, in vitro biological 
tests were performed using mouse mesenchymal stem cells cultured in chondrogenic medium 
to assess the cell viability, proliferation, morphology, and glycosaminoglycans quantification.  
 
 Preparation of scaffolds 
Collagen gel in aqueous acetic buffer solution (pH = 3.5), isolated from horse tendon, was 
purchased from OPOCRIN SpA, Italy. 1 wt% of collagen gel was diluted in milli-Q water, and 
assembling of collagen fibers was achieved by increasing the pH up to 5.5 (isoelectric point of 
82 
 
collagen) with slow dripping of 0.1 M NaOH in aqueous solution (Sigma-Aldrich, USA). 
Collagen fibers were washed three times with milli-Q water and separated from the solvent by 
sieve. Next, two different crosslinking strategies by ribose glycation was performed obtaining 
3D collagen-ribose constructs as follow (Fig. 4.1):  
A. Pre-crosslinking (PRE, before freeze-drying): collagen fibers were mixed with 50 ml of 
30 mM D-(-)-ribose (Sigma-Aldrich, USA) in ethanol/PBS (70% v/v) solution in two different 
weight ratio 1:1 and 1:0.5 (collagen:ribose) [65], [70]. Then, the crosslinking reaction was 
carried out at 37 °C for 2 or 5 days gently shaking. After 2 and 5 days of glycation solution was 
removed by using the sieve, collagen fibers were washed three times with milli-Q water, poured 
into polystyrene 48-well plate and freeze-dried by freezing at -40 °C and drying at 25 °C (5 
Pascal, LIO 3000 PLT, Italy) for 48 h under a constant vacuum of 0.1 mbar to obtain porous 
3D matrices. The developed samples will be hereafter named PRE 2D ½, PRE 2D 1, PRE 5D 
½ and PRE 5D 1. 
B. Post-crosslinking (POST, after freeze-drying): collagen fibers were firstly poured into 
polystyrene 48-well plate and freeze-dried as described above to obtain 3D constructs. 
Secondly, scaffolds were immersed in 50 ml of 30 mM D-(-)-ribose in ethanol/PBS (70% v/v) 
solution in two different weight ratio 1:1 and 1:0.5 (collagen:ribose) [65], [70]. Then, the 
crosslinking reaction was carried out at 37 °C for 2 or 5 days gently shaking. Next, scaffolds 
were washed three times with milli-Q water and freeze-dried as described above. The developed 
samples will be hereafter named POST 2D ½, POST 2D 1, POST 5D ½ and POST 5D 1. In 
total eight compositions were prepared, detailed in the Table 4.1. 
 
Fig. 4.1. Schematic illustration of fabrication ribose-crosslinked collagen scaffolds by two 
different crosslinking strategies: PRE- and POST-crosslinking. The image on the up right 
represents PRE and POST constructs as well as non-crosslinked collagen scaffold (nXL coll). 
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 Before the synthesis of designed compositions described above, various amount of ribose 
in pre- and post-crosslinking method were tested as follow: 2 wt%, 5 wt%, 10 wt%, 25 wt%, 
50 wt% and 100 wt% (weight percent respect to collagen weight, i.e. 1:1 collagen:ribose ratio). 
Crosslinking reaction was carried out for 2 and 5 days in milli-Q water and in the solution of 
ethanol/PBS (70% v/v) applying different temperature as 37 °C , 4 °C and room temperature. 
Only compositions with the collagen:ribose weight ratio 1:0.5 and 1:1 crosslinked in 
ethanol/PBS solution at 37 °C demonstrated stability over 7 days in PBS (pH = 7.4) at 37 °C 
based on macroscopic observation. Other samples showed to be unstable and start to degrade 
after one week of test. Therefore, the weight ratio 1:0.5, temperature 37 ˚C and ethanol/PBS 
solution have been established as a baseline for the conditions of crosslinking reaction. Proper 
experiments and comparative analysis have been performed on the compositions described 
above and summarized in table 4.1.  
Crosslinking 
strategy 
Time of crosslinking 
reaction 
Collagen:ribose weight 
ratio 
Abbreviations 
Pre-crosslinking 
2 days 
1:0.5  PRE 2D 1/2 
1:1  PRE 2D 1 
5 days 
1:0.5 PRE 5D 1/2 
1:1  PRE 5D 1 
Post-crosslinking 
2 days 
1:0.5  POST 2D 1/2 
1:1  POST 2D 1 
5 days 
1:0.5  POST 5D 1/2 
1:1  POST 5D 1 
Non-crosslinked collagen nXL coll  
Table 4.1. Scaffold compositions and abbreviations. 
 
 Scaffolds characterization 
3.3.1. Optimization of crosslinking conditions 
 According to lack of previous experience in the ribose crosslinking in our laboratory and 
little information in literature about optimal crosslinking conditions, several different 
compositions variable in concentration of ribose and time of reaction were tested (Table 4.1). 
This section contains characterization of eight various compositions of the collagen scaffolds 
focusing on their micro-architecture, capability to absorb fluid, biodegradability, extent of 
crosslinking and mechanical behaviour. Non-crosslinked collagen (nXL) was used as a control 
in each evaluation. 
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Porosity and pore size 
 Table 4.2 presents characterization of ribose-crosslinked collagen scaffolds based on their 
average pore size at minimum and maximum diameter and porosity obtained by water 
squeezing method (percentage of macropores porosity) and gravimetric method (percentage of 
total porosity). Regarding total porosity PRE samples showed 93% and POST samples 97% of 
porosity.   
Since macropores are essential to provide space for vascularization and tissue ingrowth in in 
vivo condition and to enhance cell proliferation in vitro, macropores porosity (%) was measured 
(Table 4.2) [37]. The percentage of macropore porosity was higher for POST samples compared 
to PRE without particular differences among POST compositions (84 – 90%). In the PRE group 
macropore porosity (%) increased corresponding to increasing time of the crosslinking reaction; 
from 65 ± 4,9% for PRE 2D 1 to 77 ± 1,4% for PRE 5D 1 (Table 4.2).  
 
 
Table 4.2. Morphological characteristics of collagen-ribose scaffolds. Percentage of porosity 
measured by gravimetric method (total porosity) and water squeezing method (macropore 
porosity) (n = 3 data are mean ± SEM). The pore size (µm) determined by analysis of the SEM 
images; maximum and minimum diameter of at least 20 pores randomly chosen from different 
images per sample were measured (n = 20, data are mean ± SEM). 
 
Average pore size in minimum and maximum diameter in dry state was measured manually 
from the SEM images of the scaffolds and it varied from around 100 µm up to approximately 
200 µm without significant differences among the samples (Table 4.2).  
 Morphological analysis of the collagen scaffolds revealed that glycation by ribose did not 
change significantly porosity and pore size in both PRE and POST group compared to nXL 
Scaffold type Composition 
Porosity (%) Average 
pore size 
(µm)  min 
diameter 
Average 
pore size 
(µm)  max 
diameter 
Gravimetric 
method 
Water 
squeezing 
method 
PRE-crosslinked 
PRE 2D 1/2 93,3 ± 0,3 67 ± 0,7 118 ± 5,5 204 ± 11,0 
PRE 2D 1 93,2 ± 0,2 65 ± 4,9 138 ± 7,3 244 ± 14,2 
PRE 5D ½ 93,7 ± 0,8 75 ± 1,9 107 ± 6,3 183 ± 6,7 
PRE 5D 1 95,2 ± 0,3 77 ± 1,4 128 ± 6,8 235 ± 9,1 
POST-
crosslinked 
POST 2D 1/2 96,5 ± 0,4 84 ± 0,7 88 ± 3,7 162 ± 8,7 
POST 2D 1 97,2 ± 0,0 90 ± 0,3 144 ± 5,3 180 ± 7,9 
POST 5D 1/2 97,1 ± 0,1 89 ± 1,1 129 ± 5,4 212 ± 7,9 
POST 5D 1 96,1 ± 0,4 88 ± 1,0 121 ± 7,3 184 ± 9,7 
Non-crosslinked 
collagen 
nXL coll 98,0 ± 0,0 75 ± 3,3 120 ± 4,3 194 ± 8,0 
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coll. Furthermore, extent of porosity and average pore size are sufficient for cell migration in 
all compositions [25], [51]. 
 
Fluid uptake  
Good swelling properties of the scaffolds are highly required when designing biomaterials 
for tissue engineering application. The capacity to absorb fluid from surrounding medium is an 
important factor because can define retention of cell medium and other physiological fluids in 
vivo which results in cell infiltration and attachment into the scaffolds [73]. As can be seen in 
Fig. 4.2, all the ribose-crosslinked collagen scaffolds absorb PBS very rapidly, reaching 
equilibrium after only 1 – 30 min of immersion for PRE compositions or from 2 to 4 h for POST 
compositions. The swelling test showed that for both PRE and POST scaffolds, crosslinking 
time of 5 days was more favourable than 2 days. There was no significant difference between 
the samples concerning the amount of ribose. Additionally, Fig. 2 demonstrated that POST 
samples have higher fluid index (%) than PRE samples: at 4 h the maximum value of fluid 
uptake observed for POST 5D ½ was 2061 ± 89% whereas, for PRE 5D 1 reached 1296 ± 33 
%. The differences in fluid binding capacity can be correlated to the different total porosity 
(Table 4.2) and hydrophilicity of the scaffolds [37]. It was noticed that post-crosslinked 
scaffolds, featured with higher porosity showed higher degree of fluid uptake.  
 
Fig. 4.2. Fluid uptake as a function of time of ribose-glycated collagen scaffolds in PBS at 37 
°C (n = 3 data are mean ± SEM). 
 
In vitro degradation and extent of crosslinking 
To evaluate biodegradability of ribose-crosslinked collagen scaffolds, enzymatic digestion 
by collagenase was carried out (Fig. 4.3). Firstly, non-crosslinked collagen samples (nXL coll) 
were treated with different amount of collagenase and their degradation profiles are presented 
in Fig. 4.3 A. Higher enzyme activity resulted in higher degradation rate (%) in shorter time; 
using 38 CDU (collagen digestion unit) nXL coll was completely degraded in 3 h, whereas 
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using 13 CDU complete degradation was obtained after 26 h. Collagen sample incubated with 
22 CDU of collagenase dissolved after 6 h and this time seemed to be optimal, as degradation 
profile was not too fast or too slow, inversely to samples with other concentrations of enzyme 
(Fig. 4.3 A). Therefore, ribose-crosslinked collagen scaffolds were treated with 22 CDU and 6 
h of incubation demonstrating the greatest resistance to enzymatic degradation for POST 
samples: 2D 1, 5D ½ and 5D 1 with significance p = 0.0001 when compared to the control nXL 
coll (Fig. 4.3 B). Among PRE compositions, the biodegradability was around 80% for all 
compositions except PRE 5D 1 (67.7 ± 2.7%), which demonstrated statistically significant 
lower degradation rate compared to nXL coll (p = 0.0001). 
 
Fig. 4.3. (A) Degradation rate (%) of non-crosslinked collagen after treatment with different 
amount of collagenase expressed as enzyme activity (CDU: collagen digestion unit) per sample. 
(B) Extent of degradation of ribose-glycated collagen scaffolds after collagenase treatment with 
22 CDU of enzyme at 6 h (n = 3, data are mean ± SEM). ****p ≤ 0.0001, *p ≤ 0.05 statistically 
significant difference when compared to the control nXL coll. 
 
Extent of crosslinking was calculated as the percentage of primary amine groups’ 
crosslinked by ribose glycation, as illustrated in Fig. 4.4. The crosslinking degree of POST 
scaffolds ranged from 13 ± 1.25% for 2D ½ to 26 ± 0.89% for 5D 1 as ribose amount and days 
of crosslinking increased. The PRE scaffolds were crosslinked in lower extent than POST 
scaffolds and the differences between days and ribose concentration among PRE samples were 
negligible. Their values ranged between 5 ± 2.00% for 2D ½ and 9 ± 0.95% for 5D 1 (Fig. 4.4). 
Relatively low crosslinking degree in ribose-glycated scaffolds is not surprising considering the 
data from literature. Not very high values of crosslinking index have been found in studies about 
non-enzymatic crosslinking by reducing sugars [74]. An explanation of this behaviour can be a 
different mechanism of crosslinking occurred in glycation process and in crosslinking by 
chemical components as 1,4-butanediol diglycidyl ether (BDDGE) or 1-ethyl-3-(3-
dimethylamino propyl) carbodiimide hydrochloride (EDC) [61], [75]. In non-enzymatic 
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crosslinking, a reducing sugar can bind the primary amine group of lysine residue of collagen 
molecule, and this glycated lysine residue can react with arginine residue on another collagen 
molecule creating the intermolecular bridge [63]. In chemical crosslinking by BDDGE, epoxide 
group of this component can react with the primary amine group of lysine residues as well as 
with the secondary amine groups of histidine. Additionally, reactions with the carboxylic acid 
groups of aspartic and glutamic acid can also occur, thereby increasing the possibility of greater 
number crosslinked bridges between collagen molecules [75], [76].  
 
Fig. 4.4. Percentage of crosslinking degree express as an amine group content crosslinked per 
scaffold (n = 3 data are mean ± SEM). 
 
The crosslinking index data can be related to the resistance upon enzymatic degradation. 
High and similar percentage of biodegradability for PRE group, apart from the sample 5D 1, 
can be explained by similar and small amount of amine groups’ crosslinked (Fig. 4.4). The 
composition PRE 5D 1 had the highest crosslinking degree among PRE scaffolds thus this 
sample was the most stable. The crosslinking index of POST scaffolds also increased adequately 
to the rise of their biostability (Fig. 4.3 and Fig. 4.4). In overall, these results indicated that post-
crosslinking strategy could be more efficient in terms of amount of crosslinked collagen 
molecules and material’s stability.  
 
Mechanical properties (elastic modulus) 
 It is well-known that cellular activity can be influenced by the stiffness of the material thus, 
scaffolds in 3D cell culture need to be stiff enough to withstand cell contractile forces [25]. In 
order to understand the mechanical properties of ribose-glycated collagen scaffolds uniaxial 
compression test was performed and elastic modulus (Young’s modulus, compressive modulus) 
was calculated for each sample.  
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Fig. 4.5 A and B showed elastic moduli of PRE and POST group respectively, focusing on 
relation between days of glycation and amount of ribose. It can be clearly seen that ribose 
crosslinking reinforced collagen manifesting significant improvement in values of compressive 
modulus of all compositions compared to nXL coll (Fig. 4.5). In the PRE group, modulus 
slightly increased between samples 2D ½ and 5D ½ along with increasing concentration or days 
of crosslinking however without evident differences (Fig. 4.5 A). Then, at the longest time and 
at the highest concentration of ribose compressive modulus increased up to 6.7 ± 0.6 kPa as 
showed PRE 5D 1 scaffold (Fig. 4.5 A). Similar trend was observed among POST samples 
demonstrating compressive moduli of around 4 kPa for POST: 2D ½, 2D 1 and 5D ½ and then 
great increase of 11.4 ± 0.3 kPa for POST 5D 1 (Fig. 4.5 B). Interestingly, increasing amount 
of ribose did not significantly influence mechanical behaviour in neither PRE nor POST 
samples crosslinked for 2 days whereas, double amount of ribose in both PRE and POST 
constructs crosslinked for 5 days significantly enlarged compressive modulus (*p ≤ 0.05, ***p 
≤ 0.001, Fig. 4.5 A, B).  
 
Fig. 4.5. Mechanical properties of ribose-crosslinked collagen scaffolds. (A) Compressive 
moduli of PRE 1 and PRE ½ crosslinked for 2 (2D) and 5 days (5D); (B) Compressive moduli 
of POST 1 and POST ½ crosslinked for 2 (2D) and 5 days (5D); (A) and (B) statistically 
significant difference observed between 5D samples in both group: *p ≤ 0.05 in PRE, ***p ≤ 
0.001 in POST; No statistically significant differences observed (ns) between samples 
crosslinked for 2D in both PRE and POST group; nXL collagen used as control. 
 
 From these mechanical analysis can be concluded that: i) stiffness of the collagen scaffolds 
increased upon ribose glycation and ii) that glycation for 5 days in the highest collagen:ribose 
ratio (1:1) manifested to be the most efficient crosslinking condition to obtain mechanically 
stable collagen scaffolds for both pre- and post-crosslinking strategy. It is also important to 
highlight that in all tests the scaffolds were hydrated prior to testing in order to mimic realistic 
conditions thereby, moduli of materials in a dry state cannot be confront to the moduli in a wet 
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conditions [77]. Nevertheless, the elastic moduli of fabricated scaffolds were similar or higher 
than those of other collagen based scaffolds found in the literature [73], [78], [79]. 
 
3.3.2. Evaluation of final compositions 
 Taken collectively the results presented so far, POST 5D 1 and PRE 5D 1 showed the best 
performance on enzymatic degradation and mechanical stability thus those compositions were 
selected for further more detailed characterization and biological analysis. 
 
Fourier Transform Infrared Spectroscopy (FTIR) 
Fig. 4.6 represents FTIR analysis of PRE 5D 1, POST 5D 1 glycated samples, non-
crosslinked collagen and ribose which serve as a control and reference respectively. 
Characteristic FTIR spectrum of nXL coll with absorption bands of amide I at ~ 1650 cm-1, 
amide II at ~ 1560 cm-1 and amide III as set of three weaker bands centred at ~ 1254 cm-1 was 
observed (Fig. 4.6) [80]. These characteristic peaks of amides were also noticed for both PRE 
and POST sample, indicating that the conformation of collagen was not significantly altered by 
ribose attachment. In order to compare spectra of crosslinked samples and crosslinker by itself, 
FTIR spectrum of D-ribose was analyzed as well, showing intense peaks between 1000 and 
1100 cm-1 (Fig. 4). These correspond to C-O, C-C stretching vibrations and C-O-H and C-C-O 
bending vibrations of ribose [65]. Although, the sharp peak at ~ 1030 cm-1 correlated to ribose 
conformation was observed also for nXL coll, the second peak at ~ 1080 cm-1 seems to be less 
sharp and shifted compared to PRE 5D 1 and POST 5D 1. Presence in nXL coll spectrum typical 
peaks of ribose can be associated with immense amount of chemical functional groups of 
collagen molecule [80].  
 
Fig. 4.6. FTIR spectra of non-crosslinked collagen (nXL coll), ribose alone and glycated 
scaffolds (PRE 5D 1 and POST 5D 1). 
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Morphology and microstructure 
 Morphology of the PRE and POST scaffolds as well as nXL coll was analysed by SEM and 
representative images are exposed in Fig. 4.7. Two different regions of the scaffold are 
displayed, starting from the top of the scaffold after transversal cut and the inside of the scaffold 
after longitudinal cut. Morphological observation showed homogeneity throughout the entire 
scaffold and porous microstructure with interconnected micro- and macropores for all samples 
(Fig. 4.7). Comparing SEM images of crosslinked samples and non-crosslinked control can be 
concluded that the glycation reaction did not modify excessively the microscopic structure of 
the collagen scaffold.  
 Considering that those scaffold are designed to be used in physiological conditions, we 
were interested in analysis of mean pore size after swelling therefore, cross-sections of wet PRE 
5D1 and POST 5D1 scaffold, embedded in OCT and cut on the cryostat were analyzed with the 
optical microscope (a typical image was reported in the insert of Fig. 4.8 A). The analyses 
revealed around 20% and 30% larger pore size after swelling for PRE 5D 1 and POST 5D 1 
respectively (calculated respect to data in Table 4.2). Average pore size measured at minimum 
diameter was 167 ± 10.6 µm for PRE and 156 ± 7.2 µm for POST, and average pore size 
measured at maximum diameter was 288 ± 9.3 µm and 279 ± 12.0 µm for PRE and POST 
respectively.  
 
 
Fig. 4.7. Morphology of pre-crosslinked (PRE 5D 1), post-crosslinked (POST 5D 1) collagen 
scaffolds and non-treated collagen (nXL). (A) transversal cross-sections, (B) longitudinal cross-
sections. Scale bars: (A) PRE 5D 1 - 500 µm, POST 5D 1 and nXL coll – 400 µm; (B) all 1000 
µm. 
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 Additionally, pore size distribution in the wet state was also evaluated as presented in Fig. 
4.8 A. The analyses demonstrated the wide distribution of pores dimension from 60 µm up to 
even 380 µm however, the highest number of pores for PRE 5D 1 was found in a range 160-
200 µm and for POST 5D 1, the highest amount of pores was noticed between 80 and 120 µm. 
More frequent presence of small pore size in POST scaffolds can be a result of double freeze-
drying process during the synthesis. This notably heterogeneous pore size distribution makes 
both PRE and POST group versatile for tissue engineering application. It has been demonstrated 
that mature chondrocytes have high proliferation rate and increased ECM production when 
seeded on the scaffolds with pore size bigger than 250 µm [51]. Nevertheless, in other studies 
has been proved that pore size around 100 µm is preferred for chondrogenesis [81] and 
moreover, pore size between 60 and 200 µm has been shown to enhance cartilage formation in 
a porcine animal model [14]. Therefore, the pore size range of PRE and POST collagen scaffold 
can be considered as an optimum for the differentiation and maintaining cell phenotype as well. 
 
 
Fig. 4.8. (A) Pore size distribution of PRE 5D 1 and POST 5D 1 after 24 h of swelling in PBS 
and representative image of 20 µm section of ribose-collagen scaffold, embedded in OCT and 
cut on the cryostat also after the immersion. The graph represents data from 150 pores randomly 
chosen from 10 images, 5 different sections; (B) Percentage of porosity measured by 
gravimetric method (Method I) and water squeezing method (Method II) (n = 3 data are mean 
± SEM); Statistically significant difference in porosity (%) observed between samples 
measured by method II: **p ≤ 0.01.  
 
 Comparing again porosity measured by gravimetric method (Method I) and water 
squeezing method (Method II) between PRE 5D 1 and POST 5D 1 there is no remarkable 
difference in the first one, however there is the statistically significant change (**p ≤ 0.01) in 
macropore porosity favourable for POST sample (Fig. 4.8 B). Lower porosity in the PRE group 
can be explained considering that, the pre-crosslinking strategy leads to a lowering of the 
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collagen hydrophilicity and a consequent decreasing in the gel water content. Because the 
amount of water before freeze-drying determines the final total porosity and consequently the 
final scaffold became less porous. This probable minor amount of free hydrophilic groups for 
PRE scaffolds results in lower fluid binding capacity in contrast to the POST samples as has 
been shown in the swelling test (Fig. 4.2).  
 
Mechanical properties 
 After preliminary static compression test presented in previous section of this chapter more 
mechanical analyses, only on PRE 5D 1 and POST 5D 1 scaffolds, were performed including 
static and dynamical mechanical test as well as creep test.  
As articular cartilage experiences continuous compression the collagen scaffolds were exposed 
to compressive loading under wet condition and at temperature 37 °C. All samples were 
incubated 24 h in PBS for swelling prior to any test.  
 Fig. 4.9 A shows stress-strain curves of PRE 5D 1, POST 5D 1 and nXL coll obtained from 
the uniaxial compression test under the controlled force. We can observe typical for soft 
polymers non-linear strain-stress curves in compressive mode. The curves confirmed distinct 
material response regarding different crosslinking methods and the control. The final fracture 
(collapse region) is difficult to notice, rather the samples underwent immediate densification 
after the linear response [27], [73].  
From the linear part of stress-strain curve compressive moduli were calculated showing 
significant enhancement in their values for crosslinked scaffolds compared to control; 12-fold 
increase for POST 5D 1 and 7-fold increase for PRE 5D 1 respect to nXL coll (both ****p ≤ 
0.0001, Fig. 4.9 B). POST scaffold exhibited also better ability to withstand the compressive 
forces which was proved by almost 2-fold significantly higher modulus compared to PRE 5D 
1 (****p ≤ 0.0001, Fig. 4.9 B). 
 To determine viscoelastic properties of the scaffolds dynamical mechanical test (DMA) at 
varying frequencies and creep test were performed. Looking at the graph of storage modulus 
the increase of E’ with increasing frequency was observed for both PRE and POST sample and 
control (Fig. 4.9 C). Storage modulus cannot be referred to compressive modulus however also 
here similar trend can be noticed i.e., promotion of E’ by glycated scaffold compared to control. 
POST sample showed the highest E’ at each frequency thus, this scaffold enhanced stiffness of 
collagen in a greater extent than PRE.  
Creep test is a common analysis used in cartilage TE because it can investigate material’s 
capacity to recover after mechanical deformation as well as can define time needed for that 
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recovery [82], [83]. In this study, scaffolds were subjected to the constant stress for 15 min 
(loading) and left without any force applied for another 15 min (deloading). Average DMA 
creep curves expressed as change of strain (%) in a function of time are displayed on Fig. 4.9 
D. After 15 min of loading the related strain values yielded 33 and 45% for POST 5D 1 and 
PRE 5D 1, respectively and then the load was stopped (Fig. 4.9 D). Strain of both scaffolds 
decreased immediately and at 30 min reached 5% for PRE 5D 1 and 3% for POST 5D 1. This 
behaviour can be confirmed by values of strain recovery (%) calculated from the creep curve. 
Both constructs showed high strain recovery at the end of the test: 95% of strain recovery for 
PRE and 97% for POST.  
 
Fig. 4.9. Detailed mechanical properties of PRE 5D 1 and POST 5D 1 collagen scaffolds. (A) 
Mean stress-strain curves of PRE 5D 1, POST 5D 1 and nXL coll; (B) Compressive moduli of 
crosslinked scaffolds and the control; statistically significant increase of modulus for POST 5D 
1 compared to the PRE 5D 1: ****p ≤ 0.0001 and also for both POST and PRE compared to 
nXL coll (not shown on the graph): ****p ≤ 0.0001; (C) Storage modulus (E’) measured by 
dynamic compression test; (D) Creep test expressed as strain change (%) during loading and 
deloading in a function of time. All samples were hydrated in PBS at 37° C for 24h prior to 
testing (n = 3 for the uniaxial compression, n = 4–5 for the dynamic and creep test, data are 
mean ± SEM).  
 
We can notice that even with higher extent of deformation at the beginning of the test and also 
after 15 min in PRE respect to POST, at 30 min PRE scaffold restored its initial height in the 
same rate as POST (Fig. 4.9 D).  nXL coll as a control has not been plotted on the graph as by 
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applying the same stress (0.002 MPa) after 5 min of loading the sample completely collapsed. 
Concluding, both PRE 5D 1 and POST 5D 1 manifested their elastic behaviour upon 
compression showing fast recovery and almost complete persistence of the original shape after 
loading and deloading. 
 Mostly, dense structure of the material results in good mechanical strength but lower 
porosity therefore, balance between mechanical properties and porosity of the scaffold can be 
extremely difficult to accomplish [1], [33]. Remarkable porous microstructure of our scaffolds 
have not been compromised by enhance of mechanical stiffness in pre- or either post-
crosslinking strategy (morphology and microstructure section). Probably higher compressive 
and storage modulus for POST than PRE can be correlated to abundance in smaller pores and 
greater amount of amine groups crosslinked as reported by crosslinking degree values in case 
of POST scaffold (Fig 4.4, Fig. 4.8 A). 
 
 Biological assessment 
Cell viability and morphology 
 To investigate the impact of ribose-crosslinked collagen on cell behaviour, mMSCs were 
seeded on PRE 5D 1 and POST 5D 1 scaffolds and cultured for 28 days in chondrogenic 
medium. 
 
Fig. 4.10. Cell viability analyzed by the Live&/Dead assay (Calcein stains live cells in green, 
Ethidium homodimer-1 stains dead cells in red) on cell seeded PRE 5D 1 and POST 5D 1 
scaffolds at day 1, 3 and day 7. Scale bars: 200 µm. 
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 Fig. 4.10 represents cell viability assessed by Live&/Dead assay at 1, 3 and 7 days of culture 
demonstrating overall high cell viability for both POST and PRE samples. The cell density 
increased over the time of culture and cells appeared to be uniformly distributed in both the 
scaffolds upper surface (Fig. 4.10). 
From the quantitative analysis of cell viability we can observed statistically significant increase 
of live cells for PRE respect to POST (p ≤ 0.05) at day 3 of culture and, on the contrary, a 
statistically significant decrease of live cells for PRE respect to POST (p ≤ 0.01) at day 7 (Fig. 
4.11 A). Moreover, the % of cell viability for PRE was reduced from 88 ± 2% to 71 ± 2% from 
day 1 to day 7 whereas, for POST scaffold it remained approximately over 80% at each day 
(Fig. 4.11 A).  
 
Fig. 4.11. Cell viability and proliferation analysed by Live&/Dead assay. (A) Percentage of live 
cells respect to the total cells counted seeded on PRE 5D 1 and POST 5D 1 scaffolds at day 1, 
3 and 7. (B) Number of live cells seeded on PRE 5D 1 and POST 5D 1 scaffolds at day 1, 3 and 
7. (A) and (B) represent mean data ± SEM from two samples, in total 6 random fields of view 
(n=6) at the same magnification per group. *p ≤ 0.05; **p ≤ 0.01. 
 
Quantification of the cell proliferation was also evaluated showing the augmentation in cell 
growth over time for all the scaffolds (Fig. 4.11 B). Higher proliferation rate was observed for 
the POST group respect to PRE group at each time point and this difference was statistically 
significant at day 3 and day 7 (p ≤ 0.01, Fig. 4.11 B). Taking together these results can be clearly 
seen that ribose did not hinder the cell growth and the cell viability (Fig. 4.11 A, B).  
Furthermore, we observed the increasing glycosaminoglycans production until 28 days of 
culture (discussed in details below) which point us to claim that cells seeded on PRE scaffolds 
were viable and active even at the late time of the culture.  
Cell morphology and cell colonization of the scaffolds were evaluated by SEM images at 
day 3, as displayed on Fig. 4.12. Cells attachment on the upper (Fig. 4.12 A) and inner surface 
(Fig. 4.12 A) of the scaffolds was noticed for both PRE 5D 1 and POST 5D 1. These results 
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proved that suitable pore size and topography of scaffold surface can promote cell colonization 
and adhesion [25].  
 
Fig. 4.12. Morphology of cell-seeded ribose-glycated collagen scaffolds at day 3. (A) top of the 
scaffold, (B) inside the scaffold. Scale bars: (A, B) 100 µm. Cells marked by  
 
Glycosaminoglycans content 
Another parameter, which can be monitored in vitro regarding cartilage tissue engineering, 
is the quantification of sulphated glycosaminoglycans (GAGs). The abundance of GAGs 
contributes to chondrogenic phenotype of the cells and it can also be considered as an index of 
functionality of differentiated cells [84], [85].  
 
Fig. 4.13. GAG deposition by cells on PRE 5D 1 and POST 5D 1 scaffold after 21 and 28 days 
of culture. Values are reported as mean ± SEM (n=3), *p ≤ 0.05. 
 
Thus, after 21 and 28 days of 3D culture in chondrogenic medium, GAG assay was performed 
on PRE 5D 1 and POST 5D 1 constructs. The amount of GAGs produced by the cells in 
correspondence to the culturing time was increased from day 21 to day 28 for both PRE and 
97 
 
POST scaffolds (Fig. 4.13). Additionally, POST sample manifested the significantly higher 
level of GAGs content when compared to PRE at day 28 (p ≤ 0.05), which can be a good 
indicator of rich deposition of cartilage ECM components by the cells.  
 
 Concluding the biological findings in this study, it was evidently estimated that both pre- 
and post-crosslinked scaffolds showed cytocompatibility, promotion of cell colonization and 
secretion of GAGs; however, POST construct turned to be superior to PRE in all these 
parameters. Better biological performance in POST 5D 1 than in PRE 5D 1 can be correlated 
with the differences in physical characterization of the scaffolds. It has been postulated that 
stiffness of the substrate can influence cell motility, morphology, proliferation and stem cell 
fate [86], [87]. Cells seeded on the stiff matrices proved to be more rigid and well spread in 
contrast to increased cell motility on flexible substrates [88]. Additionally, it has been 
demonstrated that different mechanical properties of hydrogels influenced proliferation of 
fibroblasts in 3D culture [89]. In our study, the greater stiffness expressed as elastic modulus 
by POST 5D 1 scaffold can be correlated to the higher cell proliferation rate and higher GAG 
deposition in this construct respect to PRE 5D 1 [86], [87], [90]. In addition, better swelling 
properties in POST respect to PRE group helped in providing the required microenvironment 
for cell migration and proliferation [1].  
 In the scientific community, there are still some doubts regarding cytotoxicity caused by 
glycation because large amount of the advanced glycation end products released in this process 
can contribute to the altered ECM and cell death. In fact, collagen matrices post-glycated at the 
ribose concentration higher than 30 mM have been proved to be toxic for the human lung 
fibroblasts [71]. In this work, to avoid any cytotoxic effects without compromising material 
stiffness and resistance to degradation, the final ribose concentration was 30 mM with 
corresponding to it suitable collagen-ribose weight ratios.  
We cannot omit that further biological analyses may help for better understanding the cell-
scaffold interactions. Deep investigation of the scaffolds impact on stem cells differentiation by 
gene and protein expression analyses needs to be performed in future experiments. Moreover, 
it would be more than interesting to verify mechanical properties of the cell-seeded scaffolds 
during in vitro culture.  
Last remarks 
Differences in physical and mechanical characterization as well as in biological 
performance between PRE and POST scaffolds can be attributed to the different strategies of 
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scaffolds fabrication, which contribute to distinct ribose distribution in the scaffolds. 
Hypothetic mechanism of ribose attachment to the collagen matrix has been proposed as 
depicted in Fig. 4.14. From our point of view in PRE-crosslinking, ribose molecules can react 
freely with collagen molecules that are later closely packed due to the subsequent freeze-drying 
process. In this way, ribose units can be entrapped by collagen fibers and they are mainly 
accumulated inside the collagen matrix and less on its surface (Fig. 4.14 left panel). Instead, in 
POST-crosslinking, ribose reacts with already formed collagen matrices; it can penetrate the 
3D freeze-dried scaffold due to its high porosity and creates crosslinking bonds between 
collagen fibers on its surface. In consequence, ribose can probably work as a ‘protective coat’ 
for collagen resulting in smaller biodegradation rate and higher mechanical stability (Fig. 4.14 
right panel). Moreover, ribose units which are distributed on the collagen surface in POST 
constructs can be more accessible for the cells than in PRE, promoting cell attachment and 
proliferation as ribose is also a natural saccharide which can be attractive for the cells [91], [92].   
 
Fig. 4.14. Schematic illustration of probable differences in ribose-crosslinking mechanism by 
PRE- and POST-crosslinking strategy. The illustration presents macroscopic and microscopic 
point of view. Ribose molecule marked as 
 
 Conclusions  
 In this study, an unconventional crosslinking method as non-enzymatic glycation by ribose 
was presented, which showed to be highly efficient in reinforcement of 3D collagen matrices. 
Ribose-crosslinked collagen scaffolds exhibited significantly higher resistance to enzymatic 
digestion when compared to non-crosslinked collagen. Good swelling properties and very 
porous interconnected microstructure revealed to be suitable for cell growth and colonization. 
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Comparison analysis of two crosslinking strategies: PRE- and POST-crosslinking demonstrated 
differences in fluid binding capacity, biodegradation, and extent of crosslinking degree between 
both groups with better performance for POST scaffolds. Both crosslinking methods enhanced 
mechanical properties of collagen, showing the highest compressive moduli for POST 5D 1 
construct. Moreover, it has been proved that glycation by ribose increased the stiffness of the 
collagen scaffolds without hindering their elasticity. Taken collectively the results from 
physicochemical characterization, we observed differences among the samples more in a time-
dependent manner than a dose-dependent one, favouring 5 days as an optimum time for 
sufficient crosslinking by ribose.  
Preliminary biological assessment demonstrated scaffolds cytocompatibility supported by good 
cell viability and adhesion onto the surface and inside the scaffold. POST group manifested 
significantly higher cell viability and glycosaminoglycans production than the PRE.  
 To conclude, from the comparative study of these two crosslinking strategies, the POST-
crosslinking method by ribose glycation results the most effective and promising for the 
achievement of 3D scaffolds suitable for cartilage tissue engineering. 
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PART IV 
FINAL CONCLUSIONS AND 
FUTURE PERSPECTIVES 
 
 
 Poor regenerative potential of cartilage tissue and its anisotropic complex structure makes 
cartilage restoration extremely challenging and still unsolved issue in medicine today [93]. A 
variety of barriers exist between new cartilage products and their clinical applications: a ‘gold 
standard’ treatment is still missing [94]. Nevertheless, plenty of attempts are undertaking to 
cure cartilage lesions by cartilage TE techniques. A success of such a tissue engineering strategy 
strongly depends on the choice of an appropriate scaffold and eventually suitable cell source 
[34]. The main assumption when designing and fabricating the scaffolds is their biomimicry. 
Such a biomimetic scaffold resembling the native cartilage should be able for a fast and efficient 
regeneration of a chondral defect [95]. Unfortunately, the reality is still far from the ideal. To 
provide the biocompatible material with strong physical, chemical and mechanical features is 
still a huge challenge in the field. 
 In this PhD work, we wanted to generate biomimetic-like scaffolds focusing on the 
investigation of different crosslinking strategies. For this purpose, natural polymers, gelatin and 
collagen were used to synthetize 3D porous scaffolds, as they have great potential in 
biocompatibility due to their natural origin and they relatively easily undergo physicochemical 
modifications [96]. However, both gelatin and collagen exhibit fast biodegradation in 
physiological conditions and weak mechanical properties thus, the use of proper reinforcement 
(crosslinking) is highly necessary. Among the numerous crosslinkers available on the market it 
is hard to specify which one is able to not only stabilize physically and mechanically the 
material but also improve its properties without creating cytotoxic effects [12]. Therefore, in 
this work two independent projects have been performed; the first, where comparative analysis 
among three different crosslinking methods, already existing in literature, were applied to the 
gelatin matrices and the second one where, a new type of crosslinking by glycation was used 
for fabrication of collagen scaffolds.  
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 In the first study, satisfactory results regarding scaffold’s microstructure were obtained for 
all crosslinking strategies: physical (DHT), chemical (BDDGE) and natural (Genipin). All three 
groups represented high total porosity (approx. 94%) and relatively big average pore size (over 
300 µm) without significant differences observed. Well-known fast dissolution of gelatin in an 
aqueous environment was improved in every group with superior results for G-BDD sample 
which can be correlated to its highest crosslinking degree (73%). Mechanical properties of 
gelatin were notably enhanced demonstrating the highest stiffness and better viscoelastic 
behaviour for G-DHT (compressive modulus of 54 kPa). This scaffold was able to store more 
energy maintaining the viscous response at higher frequency compared to G-BDD and G-GEN.  
Although, G-GEN manifested the strongest capability to absorb fluid and suitable porosity, this 
sample showed the highest degradation rate and the weakest mechanical properties. Moreover, 
in the biological performance, G-GEN had the lowest proliferation rate and chondrogenic 
markers expression level, putting in doubts cytocompatibility of genipin-crosslinked scaffolds. 
Cellular response for G-DHT and G-BDD were satisfied with preferable results for DHT-
crosslinked constructs.  
 In the second study, the unconventional non-enzymatic crosslinking (glycation) by 
reducing sugar – ribose was investigated focusing firstly, on optimization of crosslinking 
conditions and secondly on comparison between two different reinforcement strategies: PRE- 
and POST-crosslinking. It has been proved that glycation by ribose can be an alternative model 
of reinforcement for the collagen scaffold improving its mechanical properties and resistance 
to enzymatic degradation. To my knowledge, this is the only study using ribose as a crosslinking 
agent in the synthesis of 3D porous scaffolds. The optimal crosslinking conditions were 
established as 5 days of reaction at 37 °C using the PBS/ethanol solution with a collagen:ribose 
weight ratio of 1:1. According to comparative analysis of PRE and POST strategy, POST 
scaffolds showed better performance on degradation rate, fluid uptake, macropore porosity, 
mechanical behaviour and cellular response.  
 One of the major critical point in developing scaffolds for cartilage TE is the conflicting 
requirement of scaffolds with high porosity and mechanical strength. A highly porous structure 
is preferred in favour of cell growth and proliferation, but it is generally achieved at the expense 
of mechanical strength. In our scaffolds the balance between good mechanical properties and 
efficient porosity was achieved showing high values of elastic moduli, especially for gelatin 
scaffolds when compared to literature [2], [17], [35], [73]. Moreover, higher cell proliferation 
and higher GAGs level can be correlated to the scaffolds with superior mechanical results: G-
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DHT and POST 5D 1. This can be explained by the fact that cells seeded on the stiff matrices 
proved to interact better with biomaterial than cells seeded on flexible substrates [88].  
 Confronting together both studies performed in this thesis, gelatin scaffolds exhibited more 
porous microstructure and better mechanical properties than collagen scaffolds. Decisively, 
gelatin can be easier to manipulate and its economic value is more attractive than collagen. 
Among different crosslinking methods presented in this work, DHT showed the best potential 
in development of 3D porous scaffolds for cartilage TE. This crosslinking treatment 
demonstrated the best physicochemical, mechanical and biological performance when 
compared to other groups of gelatin scaffolds. Besides, DHT reinforcement can be superior to 
glycation by ribose, BDDGE and genipin crosslinking due to its low-cost, ease and velocity of 
the procedure that is desired for scale-up production.  
 I cannot omit that this work has some limitations, mainly in the in vitro parts. First of all, 
more tests about investigation of the scaffolds impact on cartilage formation are necessary. 
Moreover, use of primary cells is more physiologically significant and the possibility of false 
positive and negatives is smaller compared with cell lines. Therefore, more analysis of cell 
differentiation using primary cells and more complex analysis of gene expression would give 
important inputs into overall assessment of scaffolds functionalization. Finally, repetitions of 
presented studies is necessary to examine the reproducibility of research.  
 Concluding the evaluation of different crosslinking strategies used in development of 
biomimetic scaffolds for cartilage TE, this field will still require precise work to realize an ideal 
system. Nonetheless, major progress has been made recently in the cartilage repair, which give 
hope that many remaining challenges will be overcome in the near future.  
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